U.S. flag

An official website of the United States government

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

National Guideline Alliance (UK). Mental health of adults in contact with the criminal justice system: Identification and management of mental health problems and integration of care for adults in contact with the criminal justice system. London: National Institute for Health and Care Excellence (NICE); 2017 Mar. (NICE Guideline, No. 66.)

Cover of Mental health of adults in contact with the criminal justice system

Mental health of adults in contact with the criminal justice system: Identification and management of mental health problems and integration of care for adults in contact with the criminal justice system.

Show details

6Interventions

6.1. Introduction

It is widely acknowledged that there is a high prevalence of, often complex, mental health problems experienced by people in contact with the criminal justice system. Unfortunately, specific research on the mental health needs of people in contact with criminal justice system and on the effectiveness of interventions for this population has been limited. There are considerable challenges to be faced when researching interventions with this population, such as difficulties in engagement and challenges in delivering interventions in Criminal Justice settings, due to environmental constraints that are not always conducive to therapeutic interventions.

Fortunately for many people in contact with the criminal justice system, existing NICE guidance for specific conditions may well be applicable in most, if not all cases. A list of potentially relevant NICE guidelines is provided in section 1.2.5. What is not well understood, is where guidance may well not apply, how interventions may need to be adapted to be delivered effectively in the criminal justice environment. For example, do psychological interventions need be flexible to take account of difficulties of the prison environment?

Personality disorder is common in the criminal justice system as a primary or co-morbid diagnosis. People with personality disorders should not be excluded from health interventions because of personality disorder although interventions may need to be modified in duration or intensity. Interventions should facilitate learning and develop new behaviours in problem solving, emotion regulation and impulse control, managing interpersonal relationships and self-harm.

Certain issues in the prison environment that all prescribers should be aware of are the risks of overdose or diversion associated with in-possession medications, problems with administration times of not in possession (NIP) medications, particularly last dispensing times often being in early evenings (e.g. sedative anti-psychotics and anti-depressants) and the availability of medications in the first 48 hours in custody and on release. Polypharmacy, for mental health and physical conditions, is common in people in contact with the criminal justice system and should also be guarded against where at all possible. There may also be particular difficulties with medications that are open to abuse such as hypnotics and medications for chronic pain.

However, despite all these cautions, the fundamental challenge remains in effectively identifying mental problems and ensuring that people in contact with the criminal justice system are offered or referred for effective mental health treatments and are supported in accessing these treatments. It remains the case that, many, if not the majority of, such people are not accessing treatment with negative effects on their mental and physical health and a potential increase in the likelihood of reoffending.

6.2. Review question: What are the most effective interventions to promote mental health and wellbeing in adults in contact with the criminal justice system (including environmental adaptations and individual- and population-based psychoeducational interventions)?

The review protocol summary, including the review question and the eligibility criteria used for this section of the guideline, can be found in Table 46. A complete list of review questions and review protocols can be found in Appendix F; further information about the search strategy can be found in Appendix H.

Table 46. Clinical review protocol summary for the review of effective interventions to promote mental health and wellbeing in adults in contact with the criminal justice system.

Table 46

Clinical review protocol summary for the review of effective interventions to promote mental health and wellbeing in adults in contact with the criminal justice system.

6.2.1. Clinical evidence

6.2.1.1. Parent training for parent-child attachment for women with sub-threshold symptoms of depression

Two RCTs (N = 308) met the eligibility criteria for this review. Sleed et al. (2013) evaluated Better Start, a Better Start, a manualized intervention including group parent training sessions and home visits for women visits for women following release from specialized mother and baby units within prisons in England and Wales. England and Wales. Menting et al. (2014) was a Dutch study evaluating New Beginnings, a manualised manualised attachment-based group intervention developed specifically for mothers and babies in prison. An babies in prison. An overview of the trials included in the analysis can be found in Table 47. Further information about both included and excluded studies can be found in Appendix L. Summary of findings can be found in N= total number of participants

1 Number randomised

NR= Not reported

Table 48. The full GRADE evidence profiles and associated forest plots can be found in Appendices N and O, respectively.

Table 47. Study information for trials included in the analysis of parent training for parent-child attachment for women with sub-threshold symptoms of depression.

Table 47

Study information for trials included in the analysis of parent training for parent-child attachment for women with sub-threshold symptoms of depression.

Table 48. Summary of findings table for parent training versus treatment as usual for parent-child attachment for women with sub-threshold symptoms.

Table 48

Summary of findings table for parent training versus treatment as usual for parent-child attachment for women with sub-threshold symptoms.

6.2.1.2. Yoga for promoting mental health and wellbeing

One RCT (N = 167) met the eligibility criteria for this review. Bilderbeck et al. (2013) was a study of the impact of study of the impact of a ten-week yoga course on the psychological wellbeing of prisoners. Prisoners diagnosed Prisoners diagnosed with psychiatric illness were excluded. An overview of the trial included in the analysis can in the analysis can be found in Table 49. Further information about both included and excluded studies can be found in Appendix L. Summary of findings can be found in N= total number of participants

1 Number randomised

NR= Not reported

Table 50. The full GRADE evidence profiles and associated forest plots can be found in Appendices N and O, respectively.

Table 49. Study information for studies included in the analysis of Yoga versus Waitlist Control.

Table 49

Study information for studies included in the analysis of Yoga versus Waitlist Control.

Table 50. Summary of findings table for yoga versus waitlist control for promoting mental health and wellbeing.

Table 50

Summary of findings table for yoga versus waitlist control for promoting mental health and wellbeing.

6.2.1.3. Meditation for promoting mental health and well-being

One RCT (N = 33) met the eligibility criteria for this review. Sumter et al. (2009) was a US study of meditation in a study of meditation in a residential detention facility for nonviolent female probationers. An overview of the trial overview of the trial included in the meta-analysis can be found in Table 51. Further information about both included and excluded studies can be found in Appendix L. Summary of findings can be found in N= total number of participants; 1Number randomised.

Table 52. The full GRADE evidence profiles and associated forest plots can be found in Appendices N and O, respectively.

Table 51. Study information table for studies included in the meta-analysis of meditation.

Table 51

Study information table for studies included in the meta-analysis of meditation.

Table 52. Summary of findings table for meditation for promoting mental health and well-being.

Table 52

Summary of findings table for meditation for promoting mental health and well-being.

6.2.1.4. Physical exercise programmes versus exercise as usual for promoting mental health and well-being

One RCT (N =75) met the eligibility criteria for this review. Battaglia et al. (2015) was a three arm trial comparing two different physical exercise programs with exercise as usual in an Italian prison. An overview of the trial can be found in

Table 53. Further information about both included and excluded studies can be found in Appendix L. Summary of findings can be found in N= total number of participants

1 Number randomised

Table 54. The full GRADE evidence profiles and associated forest plots can be found in Appendices N and O, respectively.

Table 53. Study information table for studies included in the analysis of physical exercise programmes versus exercise as usual.

Table 53

Study information table for studies included in the analysis of physical exercise programmes versus exercise as usual.

Table 54. Summary of findings table for physical exercise programmes versus exercise as usual.

Table 54

Summary of findings table for physical exercise programmes versus exercise as usual.

6.2.2. Economic evidence

No studies assessing the cost effectiveness of interventions to promote mental health and wellbeing in adults in contact with the criminal justice system (including environmental adaptations and individual- and population-based psychoeducational interventions) were identified by the systematic search of the economic literature undertaken for this guideline. Details on the methods used for the systematic search of the economic literature are described in Chapter 3.

6.2.3. Clinical evidence statements

6.2.3.1. Parent training for parent-child attachment for women with sub-threshold symptoms

Low quality evidence from a single study (N=115) found no clinically important effects of parent training on depression as measured by mean scores on the Center for Epidemiological Studies Depression Scale or the number of participants with symptoms of depression for women with sub-threshold symptoms of depression resident in specialized mother and baby units in prison.

Low quality evidence from single study data (N=88-109) also showed no clinically important effects of parent training on:

  • measures of mother-child attachment
  • mother-child interaction
  • or maternal perceptions of their child

A single study (N=102-3) found low quality inconsistent evidence for effects of parent training on maternal perceptions of parenting as measured by the Alabama Parenting Questionnaire (APQ) for women recently released from prison.

  • For the Inconsistent discipline sub-scale, a clinically important effect was found in favour of parent training.
  • However, for the Positive parenting subscale there was a clinically important effect in favour of the treatment as usual control.
  • While for the Involvement, Poor monitoring/supervision and Corporal Punishment subscales no clinically significant effects were found.

Low quality evidence from two studies (N=308) did not indicate a clinically significant difference in drop-out between the parent training and treatment as usual conditions for women in prison or recently released from prison.

6.2.3.2. Yoga for promoting mental health and wellbeing

A single study (N=100) found very low quality evidence for clinically significant effects of yoga on increasing positive affect, decreasing negative affect and reducing perceived stress and for reducing psychological distress for participants in prison.

However, this study (N=167) also found that there was a clinically significant number of participants who dropped out of the study in the yoga condition.

6.2.3.3. Meditation for promoting mental health and well-being

A single study (N=33) found very low quality evidence for a clinically important effect of meditation for non-violent female probationers in a residential detention facility on reducing the desire to throw things or hit people and on being bothered by nail biting as measured by a study-specific scale

However, confidence in these effect estimates was very low due to serious risk of bias (unclear randomisation method and allocation concealment, lack of blinding and lack of a valid and reliable outcome measure) and very serious imprecision).

This same study found no evidence for clinically significant effects of meditation on feelings of guilt or hopelessness or being bothered by sleeping difficulties.

6.2.3.4. Physical exercise programmes for promoting mental health and well-being

Low quality evidence from one randomised controlled trial (N=75) indicated that a 9 month physical exercise programme had a clinically important beneficial effect on psychological wellbeing as measured by the Symptom Checklist-90-Revised (SCL-90-R) when compared to exercise as usual.

6.2.4. Economic evidence statements

No evidence on the cost effectiveness of interventions to promote metal health and wellbeing for adults who are in contact with the criminal justice system is available.

6.3. Recommendations and link to evidence

Recommendations No recommendation made.
Relative values of different outcomesCritical outcomes for this question included improvement in mental health and well-being; data on parenting outcomes were viewed as indicators of improved well-being. But there was no data on large scale population or service level interventions, which are commonly the focus of health promotion interventions. The GC were uncertain of the value of the available data to inform decisions about population (i.e. those in the criminal justice system) or service level interventions.
Trade-off between clinical benefits and harmsThe GC were of the view that most health promotion programmes were unlikely to have any significant harms associated with their use but there was a concern that the delivery of such programmes may increase the threshold or reduce the likelihood of interventions being offered to people with established mental health problems.

There were 6 trials of parenting interventions focussed on attachment difficulties. The studies were all of low quality and there were inconsistent indications of benefit e.g. on maternal mental health or mother-child attachment.

One very low quality study of yoga, which had high attrition, reported some evidence of benefit on positive affect. One very low quality study reported no positive benefits associated with meditation. One small low quality study reported a significant benefit on mental health symptoms following a physical exercise programme.
Trade-off between net health benefits and resource useThere was no data available on the cost effectiveness of health promotion interventions. However, in the absence of good quality evidence for the effectiveness of these interventions, the GC were concerned that it may lead to inappropriate use of resource.
Quality of evidenceThe quality of the evidence ranged from low to very low. This was due to lack of blinding, inadequate randomisation, attrition bias and imprecision in the effect estimates of the included randomised trials. The GC considered that RCT evidence was required for this question given the cost implications of implementing mental health promotion across the entire criminal justice system.

The GC had low confidence in the effect estimates which were very low for the study looking at the effects of parent training on maternal perceptions of parenting as measured by the Alabama Parenting Questionnaire (APQ) for women recently released from prison. This was due to a very serious risk of bias. Randomisation was temporarily suspended for 24.7% of participants, participants and intervention administrators were non-blind and unclear reliability and validity of the outcome measure) and very serious risk of imprecision (N<400 and wide confidence intervals).

The GC also had low confidence in the effect estimates which were very low for the study looking at yoga for promoting mental health and well-being. This was due to a serious risk of bias (due to unclear allocation concealment, non-blind participants and intervention administrators and high risk of attrition bias) and serious imprecision.
Other considerationsThe GC considered the evidence insufficient to make recommendations for mental health promotion or well-being interventions. Nor was the evidence considered sufficient to support any specific recommendations on parent training, yoga, acupuncture, meditation or physical exercise programmes. The GC were aware of a number of mental health promotion programmes that had been developed outside of the criminal justice system. They did not consider that evidence sufficient to draw on their knowledge and expertise to make an extrapolation from existing data on mental health promotion. They therefore decided not to make a recommendation.

In view of the very limited evidence of interventions in the area of suicide prevention the GC decided to make a research recommendation in this area. As a first stage research recommendation the GC felt it was important to understand the factors associated with attempted and completed suicides in the criminal justice system in order to inform the development of appropriate preventative interventions.

6.3.1. Research recommendations (see also Appendix G)

4.

What factors are associated with suicide attempts and completed suicides? (Key Research Recommendation)

There is high prevalence of suicide attempts among people in contact with criminal justice system. When developing interventions to prevent self-harm among these populations, it is important to identify and understand the factors related to successful suicide. A retrospective analysis of observational studies of suicidal attempts and completed suicides using suicide as a definitive and measurable outcome should be performed to identify the prognostic factors for successful prevention.

6.4. Review question: What interventions are effective, or what modifications are needed to psychological, social, pharmacological or physical interventions recommended in existing NICE guidance, for adults in contact with the criminal justice system who have

  • alcohol-use disorders?
  • antenatal or postnatal mental health problems [for women]?
  • antisocial personality disorder?
  • attention deficit hyperactivity disorder?
  • autism?
  • bipolar disorder?
  • borderline personality disorder?
  • challenging behaviour or mental health problems [for adults with learning disabilities]?
  • delirium?
  • dementia?
  • depression (with or without a coexisting chronic physical health problem)?
  • eating disorders?
  • generalised anxiety disorder and panic disorder (with or without agoraphobia)?
  • obsessive-compulsive disorder and body dysmorphic disorder?
  • post-traumatic stress disorder?
  • psychosis (with or without coexisting substance misuse) or schizophrenia?
  • self-harmed (self-harming)?
  • social anxiety disorder?
  • substance misuse disorders?
  • violent and aggressive behaviour [for adults with mental health disorders]?

The review protocol summary, including the review question and the eligibility criteria used for this section of the guideline, can be found in Table 55. A complete list of review questions and review protocols can be found in Appendix F; further information about the search strategy can be found in Appendix H.

Table 55. Clinical review protocol summary for the review of psychological, social, pharmacological or physical interventions that are effective for adults in contact with the criminal justice system.

Table 55

Clinical review protocol summary for the review of psychological, social, pharmacological or physical interventions that are effective for adults in contact with the criminal justice system.

6.4.1. Clinical evidence

6.4.1.1. Substance misuse

6.4.1.1.1. Psychological interventions

There were 23 studies that met the criteria for this review: Alemi 2010 (Alemi et al., 2010), Annis 1979 (Annis, 1979), Binswanger 2015 (Binswanger et al., 2015), Brown 1980 (Brown, 1980), Carroll 2006 (Carroll et al., 2006), Carroll 2012 (Carroll et al., 2012), Crane 2015b (Crane et al., 2015b), Easton 2000 (Easton et al., 2000), Easton 2007c (Easton et al., 2007c), Forsberg 2011 (Forsberg et al., 2011B), Gordon 2008 (Gordon et al., 2008), Gordon 2014 (Gordon et al., 2014), Kinlock 2007 (Kinlock et al., 2007), Kinlock 2009 (Kinlock et al., 2009), McKenzie 2012 (McKenzie et al., 2012), Miller 1975 (Miller, 1975) M, Proctor 2012 (Proctor et al., 2012), Sinha 2003 (Sinha et al., 2003), Stuart 2013 (Stuart et al., 2013), Villagara-Lanza 2013 (Villagra Lanza & Menendez, 2013), Villagara-Lanza 2014 (Lanza et al., 2014), Witkiewitz 2014 (Witkiewitz et al., 2014) and Zlotnick 2009 (Zlotnick et al., 2009).

The interventions studied included acceptance and commitment therapy (ACT), cognitive behavioural therapy (CBT), other cognitive and behavioural therapies, mindfulness-based approaches, counselling, motivational interviewing techniques, self-help and psychoeducation.

Cognitive behavioural therapy versus active intervention for substance misuse

There were 3 RCTs (N=254) that met the eligibility criteria for this review: Carroll 2012, Easton 2007c and Zlotnick 2009 (Carroll et al., 2012; Easton et al., 2007c; Zlotnick et al., 2009).

An overview of the trials can be found in Table 56. Further information about both included and excluded studies can be found in Appendix N. Summary of findings can be found in N= total number of participants

NA= Not applicable

1 Number randomised

Table 57. The full evidence profiles and associated forest plots can be found in Appendices O and P.

The Zlotnick 2009 and Easton 2007c studies both describe 2-arm trials. The Zlotnick 2009 trial compared a variation of CBT tailored specifically to substance misuse (seeking safety) with treatment based upon the 12-step recovery model, whilst the Easton 2007c trial compared a variation of CBT designed for co-occurring substance misuse and domestic violence with the 12-step model. Finally, the Carroll 2012 trial was a 4-armed trial in which service users were allocated to one of the following conditions; standard CBT alone, CBT plus contingency management for adherence, contingency management for abstinence or CBT plus contingency management for abstinence. Only the CBT alone and CBT plus contingency management for adherence arms were included within this sub-review (CBT versus active intervention). The contingency interventions in Carroll 2012 were looked at under different sub-reviews (Contingency management versus Active intervention). The Carroll 2012 and Easton 2007c studies were both conducted in the community whilst the Zlotnick 2009 trial was conducted in a residential facility. The Easton 2007c trial intervention was delivered in a group setting whilst treatment in the other 2 studies was delivered individually (Carroll 2012) or a mixture of the two (Zlotnick 2009).

The evidence for this review was low to very low quality. No data was available for the outcomes of service utilisation, adaptive functioning or rates of self-injury.

Table 56. Study information table for trials included in the analysis of CBT versus active intervention for substance misuse.

Table 56

Study information table for trials included in the analysis of CBT versus active intervention for substance misuse.

Table 57. Summary of findings table for the analysis of CBT versus active intervention for substance misuse.

Table 57

Summary of findings table for the analysis of CBT versus active intervention for substance misuse.

Cognitive behavioural therapy versus wait-list control for substance misuse

One RCT (N=27) met the eligibility criteria for this review: Villagara-Lanza 2014 (Lanza et al., 2014).

An overview of the trial can be found in Table 58. Further information about both included and excluded studies can be found in Appendix N. Summary of findings can be found in N= total number of participants;

1 Number randomised.

Table 59. The full evidence profiles and associated forest plots can be found in Appendices O and P.

The Villagara-Lanza 2014 study was a 3-arm trial, with groups receiving CBT, ACT or no treatment (waitlist control). The comparison of CBT and waitlist control group is described here. Treatment was delivered in a group format within a prison setting.

The evidence for this review was low to very low quality. No data was available for the outcomes of service utilisation, adaptive functioning or rates of self-injury.

Table 58. Study information table for trials included in the analysis of CBT versus waitlist control.

Table 58

Study information table for trials included in the analysis of CBT versus waitlist control.

Table 59. Summary of findings table for the analysis of CBT versus wait-list control for substance misuse.

Table 59

Summary of findings table for the analysis of CBT versus wait-list control for substance misuse.

Acceptance and commitment therapy versus cognitive behavioural therapy for substance misuse

One RCT (N=30) met the eligibility criteria for this review: Villagara-Lanza 2014 (Lanza et al., 2014).

An overview of the trial can be found in Table 60. Further information about both included and excluded studies can be found in Appendix L. Summary of findings can be found in N= total number of participants

1 Number randomised

Table 61. The full evidence profiles and associated forest plots can be found in Appendices N and O. respectively.

Villagara-Lanza 2014 was a 3-armed trial comparing Acceptance and Commitment Therapy (ACT), CBT and control. The comparisons of ACT versus control and CBT versus control are detailed elsewhere in this chapter. Treatment was delivered in groups in prison.

The evidence for this review was low to very low quality. No evidence was available for the outcomes of offending and reoffending, service utilisation, adaptive functioning or rates of self-injury.

Table 60. Study information table for trials included in the analysis of ACT versus CBT for substance misuse in adults within the criminal justice system.

Table 60

Study information table for trials included in the analysis of ACT versus CBT for substance misuse in adults within the criminal justice system.

Table 61. Summary of findings for the analysis of ACT versus CBT for substance misuse in adults within the criminal justice system.

Table 61

Summary of findings for the analysis of ACT versus CBT for substance misuse in adults within the criminal justice system.

Acceptance and commitment therapy versus waitlist for substance misuse

Two RCTs (N=61) met the eligibility criteria for this review: Villagara-Lanza 2013 (Villagra Lanza & Menendez, 2013) and Villagara-Lanza 2014 (Lanza et al., 2014).

An overview of the trials can be found in Table 62. Further information about both included and excluded studies can be found in Appendix L. Summary of findings can be found in N= total number of participants;

1 Number randomised

Table 63. The full evidence profiles and associated forest plots can be found in Appendices N and O, respectively.

The Villagara-Lanza 2013 study was a 2-armed trial comparing ACT and a waitlist control group. The Villagara-Lanza 2014 study was a 3-armed trial comparing ACT, CBT and waitlist control groups. The comparisons of ACT versus CBT and CBT versus control are included elsewhere within the chapter. Both trials delivered interventions in groups within a prison setting.

The evidence for this review was low to very low quality. No data were available for the outcomes of offending and reoffending, service utilisation, adaptive functioning or rates of self-injury.

Table 62. Study characteristics for the analysis of ACT versus waitlist control for substance misuse in adults within the criminal justice system.

Table 62

Study characteristics for the analysis of ACT versus waitlist control for substance misuse in adults within the criminal justice system.

Table 63. Summary of findings for the analysis of ACT versus waitlist control for substance misuse in adults within the criminal justice system.

Table 63

Summary of findings for the analysis of ACT versus waitlist control for substance misuse in adults within the criminal justice system.

Mindfulness-based relapse prevention (MBRP) versus Cognitive Behavioural Therapy (CBT) for substance misuse

One RCT (N=105) met the eligibility criteria for this review: Witkiewitz 2014 (Witkiewitz et al., 2014).

An overview of the trial can be found in Table 64. Further information about both included and excluded studies can be found in Appendix L. Summary of findings can be found in N = total number of participants

NR=Not reported

RCT=randomised controlled trial

1 Number randomised

Table 65. The full evidence profiles and associated forest plots can be found in Appendices N and O, respectively.

This was a 2-armed trial comparing mindfulness-based CBT with a CBT-based relapse prevention intervention. The authors hypothesised that the addition of a mindfulness-based component would help service users to identify when they were on ‘automatic pilot’ and accordingly assist them in identifying triggers for cravings and help prevent relapse. The interventions were provided in a group format in a residential detention setting.

The evidence for this review was very low quality. No data were available for the outcomes of offending and reoffending, service utilisation, adaptive functioning or rates of self-injury.

Table 64. Study characteristics for the analysis of mindfulness-based relapse prevention versus active intervention for substance misuse in adults within the criminal justice system.

Table 64

Study characteristics for the analysis of mindfulness-based relapse prevention versus active intervention for substance misuse in adults within the criminal justice system.

Table 65. Summary of findings table for the analysis of MBRP versus CBT.

Table 65

Summary of findings table for the analysis of MBRP versus CBT.

Contingency management versus active intervention for substance misuse

Four RCTs (N=461) met the eligibility criteria for this review: Carroll 2006 (Carroll et al., 2006), Carroll 2012 (Carroll et al., 2012), Prendergast 2015 (Prendergast et al., 2015) and Sinha 2003 (Sinha et al., 2003).

An overview of the trials can be found in

Table 66. Further information about both included and excluded studies can be found in Appendix L. Summary of findings can be found in N= total number of participants;

1 Number randomised

Table 67. The full evidence profiles and associated forest plots can be found in Appendices N and O, respectively.

The Carroll 2006 study was a 4-armed trial comparing CBT plus motivational enhancement and contingency management, motivational enhancement plus CBT only, drug counselling plus contingency management and drug counselling alone. Only the contingency management plus drug counselling and drug counselling alone arms are included within this review. The Carroll 2012 trial was a 4-armed trial in which service users were allocated to one of the following conditions; standard CBT alone, CBT plus contingency management for adherence, contingency management for abstinence or CBT plus contingency management for abstinence. Here the 3 contingency management arms are combined and compared with the CBT arm. By combing the 3 contingency management arms to create a single pair-wise comparison with CBT alone randomisation was preserved, the interventions being similar enough to not downgrade this evidence for indirectness. The Sinha 2003 study was a 2-armed trial, where participants received either contingency management plus motivational enhancement therapy, or motivational enhancement therapy alone. The Prendergast 2015 study was also a 2-armed trial comparing contingency management with a psychoeducational intervention called ‘attendance education group’.

The evidence for this review was low to very low quality. No data was available for the outcomes of adaptive functioning, offending and reoffending or rates of self-injury.

Table 66. Study information table for trials included in the analysis of contingency management versus active intervention for substance misuse.

Table 66

Study information table for trials included in the analysis of contingency management versus active intervention for substance misuse.

Table 67. Summary of findings table for the analysis of contingency management versus active intervention for substance misuse.

Table 67

Summary of findings table for the analysis of contingency management versus active intervention for substance misuse.

Contingency management versus Treatment as usual (TAU) for substance misuse

One RCT (N=20) met the eligibility criteria for this review: Miller 1975 (Miller, 1975).

An overview of the trial can be found in

Table 68. Further information about both included and excluded studies can be found in Appendix L. Summary of findings can be found in N= total number of participants; TAU = treatment as usual

1 Number randomised

Table 69. The full evidence profiles and associated forest plots can be found in Appendices N and O, respectively.

The Miller 1975 study was a 2-arm trial, with groups receiving contingency management or no treatment. Contingency management consisted of the provision of goods and services in exchange for sobriety. This trial was conducted in the community with treatment provided on an individual basis.

The evidence for this review was low quality. No data was available for the outcomes of mental health, service utilisation, adaptive functioning or rates of self-injury.

Table 68. Study information table for trials included in the analysis of contingency management versus treatment as usual substance misuse.

Table 68

Study information table for trials included in the analysis of contingency management versus treatment as usual substance misuse.

Table 69. Summary of findings table for the analysis of contingency management versus TAU for substance misuse.

Table 69

Summary of findings table for the analysis of contingency management versus TAU for substance misuse.

Motivational enhancement therapy versus active intervention for substance misuse

Three RCTs (N=362) met the eligibility criteria for this review: Carroll 2006 (Carroll et al., 2006), Easton 2000 (Easton et al., 2000) and Stuart 2013 (Stuart et al., 2013).

An overview of the trial can be found in

Table 70. Further information about both included and excluded studies can be found in Appendix L. Summary of findings can be found in Table 71. The full evidence profiles and associated forest plots can be found in Appendices N and O, respectively.

Easton 2000 and Stuart 2013 were both 2-armed trials comparing motivational enhancement with psychoeducation. Carroll 2006 was a 4-armed trial with participants randomly allocated to receive one of the following: motivational enhancement therapy plus CBT and contingency management, motivational enhancement therapy plus CBT without contingency management, drug counselling plus contingency management or drug counselling alone. The drug counselling comparisons are described elsewhere within this chapter. The interventions in the Carroll 2006 trial were delivered individually.

The available data for this review were of very low quality. No data were available for the outcomes of offending and reoffending, adaptive functioning, rates of self-injury or service utilisation.

Table 70. Study characteristics table for the comparison of motivational enhancement therapy versus active intervention.

Table 70

Study characteristics table for the comparison of motivational enhancement therapy versus active intervention.

Table 71. Summary of findings for the analysis of motivational enhancement versus active intervention.

Table 71

Summary of findings for the analysis of motivational enhancement versus active intervention.

Motivational interviewing (MI) versus control or treatment as usual (TAU) for substance misuse

Four RCTs (N=492) met the eligibility criteria for this review: Alemi 2010 (Alemi et al., 2010), Crane 2015b (Crane et al., 2015b), Davis 2003 (Davis et al., 2003) and Forsberg 2011 (Forsberg et al., 2011B).

Three trials were 2-armed (Alemi 2010, Crane 2015b and Davis 2003) and compared motivational interviewing with control or no treatment. Forsberg 2011 was a 3-armed trial that compared two different forms of motivational interviewing with treatment as usual. These two forms (with workshop training only or with peer group supervision in addition) have been combined here. All trials delivered the intervention of interest individually. Crane 2015b conducted their trial in the community whilst Davis 2003 and Forsberg 2011 conducted trials in prison settings.

An overview of the trials can be found in Table 72. Further information about both included and excluded studies can be found in Appendix L. Summary of findings can be found in N= total number of participants; NR=Not reported

1 Number randomised

Table 73. The full evidence profiles and associated forest plots can be found in Appendices N and O, respectively.

The evidence for this review was low to very low quality. No data were available for the outcomes of adaptive functioning or rates of self-injury.

Table 72. Study characteristics table for the analysis of motivational interviewing or motivational feedback compared with control or treatment as usual.

Table 72

Study characteristics table for the analysis of motivational interviewing or motivational feedback compared with control or treatment as usual.

Table 73. Summary of findings for the analysis of motivational interviewing or motivational feedback versus control or treatment as usual.

Table 73

Summary of findings for the analysis of motivational interviewing or motivational feedback versus control or treatment as usual.

Group counselling versus treatment as usual for substance misuse

1 RCT (N=150) met the eligibility criteria for this review: Annis 1979 (Annis, 1979).

An overview of the trial can be found in Table 74. Further information about both included and excluded studies can be found in Appendix L. Summary of findings can be found in N= total number of participants

TAU=treatment as usual

1 Number randomised

Table 75. The full evidence profiles and associated forest plots can be found in Appendices N and O, respectively.

This was a 3-armed trial with service users being allocated to group counselling either with or without video-feedback, or treatment as usual. Outcomes with and without video feed-back are combined here. In the analysis the data for the two group counselling arms were pooled together and compared to the treatment as usual arms, preserving randomisation. When appraising quality it was considered that the two counselling arms used very similar interventions - differing only in the use of video feedback.

The available data for this review were of very low quality. No data were available for the outcomes of adaptive functioning, rates of self-injury or service utilisation.

Table 74. Study information table for trials included in the analysis of group counselling versus treatment as usual for substance misuse.

Table 74

Study information table for trials included in the analysis of group counselling versus treatment as usual for substance misuse.

Table 75. Summary of findings for the analysis of group counselling versus treatment as usual.

Table 75

Summary of findings for the analysis of group counselling versus treatment as usual.

Self-help versus control for substance misuse

1 RCT (N=183) met the eligibility criteria for this review: Proctor 2012 (Proctor et al., 2012).

An overview of the trial can be found in Table 76. Further information about both included and excluded studies can be found in Appendix L. Summary of findings can be found in N= total number of participants;

1 Number randomised

Table 77. The full evidence profiles and associated forest plots can be found in Appendices N and O, respectively.

The RCT had 2 arms, with service users randomly allocated either to either complete a self-help journal or to receive no intervention. The purpose of the journal was to assist service users to make a connection between their substance misuse and criminal activity and was based upon the trans-theoretical model of change.

The data for this review was of a low quality. No data were available for the outcomes of mental health, service utilisation, adaptive functioning or rates of self-injury.

Table 76. Study information table for trials included in the analysis of self-help versus control for substance misuse.

Table 76

Study information table for trials included in the analysis of self-help versus control for substance misuse.

Table 77. Summary of findings for the analysis of self-help versus control for substance misuse.

Table 77

Summary of findings for the analysis of self-help versus control for substance misuse.

6.4.1.1.2. Pharmacological interventions
Opioid antagonists

These drugs bind to opioid receptors without activating them, preventing the body from responding to opioids and endorphins in the same way as they would otherwise. Naloxone is also used as an antidote drug in instances of opioid overdose, whilst Naltrexone can help reverse the long-term neurochemical after-effects of opioid misuse, which is hypothesised to help prevent relapse.

Five RCTs (N=394) met the eligibility criteria for this review: Cornish 1997 (Cornish et al., 1997), Coviello 2010 (Coviello et al., 2010), Hanlon 1977 (Hanlon et al., 1977), (Lee et al., 2016; Lee et al., 2015) and Lobmaier 2010 (Lobmaier et al., 2010).

Naloxone versus placebo

One RCT (N=154) met the eligibility criteria for this review: Hanlon 1977

An overview of the trial can be found in Table 78. Further information about both included and excluded studies can be found in Appendix L. Summary of findings can be found in N= total number of participants

1 Number randomised

Table 79. The full evidence profiles and associated forest plots can be found in Appendices N and O, respectively.

The RCT by Hanlon 1977 had 2 arms and was conducted in a community setting.

The data for this review was of very low quality. No data were available for the outcomes of offending and reoffending, service utilisation, adaptive functioning and rates of self-injury.

Table 78. Study information table for trials included in the analysis of Naloxone versus placebo for drug misuse.

Table 78

Study information table for trials included in the analysis of Naloxone versus placebo for drug misuse.

Table 79. Summary of findings table for the analysis of Naloxone versus placebo for drug misuse.

Table 79

Summary of findings table for the analysis of Naloxone versus placebo for drug misuse.

Naltrexone versus active intervention

Four RCTs (N=514) met the eligibility criteria for this review: Cornish 1997 (Cornish et al., 1997), Coviello 2010 (Coviello et al., 2010), Lee 2016 (Lee et al., 2016; Lee et al., 2015) and Lobmaier 2010 (Lobmaier et al., 2010).

An overview of the trials can be found in

Table 80. Further information about both included and excluded studies can be found in Appendix L.

Summary of findings can be found in N= total number of participants;

1 Number randomised

Table 81. The full evidence profiles and associated forest plots can be found in Appendices N and O, respectively.

These were all 2-armed trials with Naltrexone treatment in one arm and either a psychosocial intervention (3 trials) or Methadone (1 trial) in the other.

The data for this comparison was of very low quality. No data were available for the outcomes of quality of life and adaptive functioning.

Table 80. Study information table for trials included in the analysis of naltrexone versus active intervention for drug misuse.

Table 80

Study information table for trials included in the analysis of naltrexone versus active intervention for drug misuse.

Table 81. Summary of findings table for the analysis of naltrexone versus active intervention for drug misuse.

Table 81

Summary of findings table for the analysis of naltrexone versus active intervention for drug misuse.

Opioid maintenance treatment

Opioid maintenance treatment aims to minimise the harms associated with opioid use, such as blood-borne illnesses associated with needle sharing.

There were 8 RCTs (N=1,565) that met the eligibility criteria for this review: Cropsey 2011 (Cropsey et al., 2011), Dolan 2003/2005 (Dolan et al., 2003; Dolan et al., 2005), Howells 2002 (Howells et al., 2002), Magura 2009 (Magura et al., 2009), Rich 2015 (Rich et al., 2015), Sheard 2009 (Sheard et al., 2009), Shearer 2006 (Shearer et al., 2006) and Wright 2011 (Wright et al., 2011).

Methadone maintenance versus waiting list control

Four papers from 3 separate RCTs (N=1,047) met the eligibility criteria for this review: Dolan 2003 and Dolan 2005 (Dolan et al., 2003; Dolan et al., 2005), Rich 2015 (Rich et al., 2015) and Shearer 2006 (Shearer et al., 2006).

An overview of the trials can be found in

Table 82. Further information about both included and excluded studies can be found in Appendix L.

Summary of findings can be found in N= total number of participants

TAU=treatment as usual

1 Number randomised

Table 83. The full evidence profiles and associated forest plots can be found in Appendices N and O, respectively.

These were 2-armed trials with service users randomly allocated to either a Methadone treatment arm or waiting list control or forced withdrawal arm.

The data for this comparison were of low to very low quality. No data were available for the outcomes of adaptive functioning and quality of life.

Table 82. Study information table for trials included in the analysis of methadone maintenance versus waiting list control for drug misuse.

Table 82

Study information table for trials included in the analysis of methadone maintenance versus waiting list control for drug misuse.

Table 83. Summary of findings table for the analysis of methadone versus waiting list control for drug misuse.

Table 83

Summary of findings table for the analysis of methadone versus waiting list control for drug misuse.

Alpha-adrenergic agonists versus opioid maintenance for substance misuse

One RCT (N=68) met the eligibility criteria for this review: Howells 2002 (Howells et al., 2002).

An overview of the trial can be found in

Table 84. Further information about both included and excluded studies can be found in Appendix L.

Summary of findings can be found in N= total number of participants;

1 Number randomised

Table 85. The full evidence profiles and associated forest plots can be found in Appendices N and O, respectively.

This was a 2-armed trial comparing Lofexidine, an alpha-adrenergic agonist, with methadone. Lofexidine is typically managed in these settings to minimise symptoms of opiate withdrawal. This trial was conducted within a prison setting.

The quality of evidence for this review was low. No evidence was available for the outcomes of offending and reoffending, service utilisation, adaptive functioning or rates of self-injury.

Table 84. Study information table for trials included in the analysis of alpha-adrenergic agonists versus opioid maintenance for substance misuse.

Table 84

Study information table for trials included in the analysis of alpha-adrenergic agonists versus opioid maintenance for substance misuse.

Table 85. Summary of findings table for the comparison of alpha-adrenergic agonists versus opioid maintenance for substance misuse.

Table 85

Summary of findings table for the comparison of alpha-adrenergic agonists versus opioid maintenance for substance misuse.

Opioid substitution therapy versus active intervention or placebo

Four RCTs (N=450) met the eligibility criteria for this review: Cropsey 2011 (Cropsey et al., 2011), Magura 2009 (Magura et al., 2009), Sheard 2009 (Sheard et al., 2009) and Wright 2011 (Wright et al., 2011).

An overview of the trials can be found in

Table 86. Further information about both included and excluded studies can be found in Appendix L.

Summary of findings can be found in N= total number of participants;

1 Number randomised

Table 87. The full evidence profiles and associated forest plots can be found in Appendices N and O, respectively.

Each study had 2 arms with buprenorphine in one arm and an alternative opioid substitute or placebo in the other. Three studies were conducted within a prison setting whilst one was conducted in the community.

The data were low to very low quality. No data were available for the outcomes of quality of life or adaptive functioning.

Table 86. Study information table for trials included in the analysis of opioid substitution versus active intervention for substance misuse.

Table 86

Study information table for trials included in the analysis of opioid substitution versus active intervention for substance misuse.

Table 87. Summary of findings table for the analysis of opioid substitution versus active intervention or placebo for substance misuse.

Table 87

Summary of findings table for the analysis of opioid substitution versus active intervention or placebo for substance misuse.

6.4.1.2. Combined psychological and pharmacological interventions

Antidepressants plus psychological therapy versus psychological therapy alone for substance misuse

One RCT (N=60) met the eligibility criteria for this review: George 2011 (George et al., 2011).

An overview of the trial can be found in

Table 88. Further information about both included and excluded studies can be found in Appendix L.

Summary of findings can be found in N= total number of participants;

1 Number randomised

Table 89. The full evidence profiles and associated forest plots can be found in Appendices N and O, respectively.

The trial had 2 arms, with service users being randomly allocated to either receive fluoxetine, a selective serotonin reuptake inhibitor (SSRI), in addition to CBT and motivational therapy or just to receive CBT and motivational therapy. The authors report that fluoxetine was chosen for this study as SSRIs are hypothesised to modulate the processing of environmental stimuli to increase orbital frontal cortex function and accordingly reduce impulsive aggression. This trial was conducted in the community.

The available data for this review was of low quality. No data were available for the outcomes of offending and reoffending, adaptive functioning or rates of self-injury.

Table 88. Study information table for trials included in the analysis of antidepressants plus psychological therapy versus psychological therapy alone for substance misuse.

Table 88

Study information table for trials included in the analysis of antidepressants plus psychological therapy versus psychological therapy alone for substance misuse.

Table 89. Summary of findings table for antidepressants plus psychological therapy versus psychological therapy alone for substance misuse.

Table 89

Summary of findings table for antidepressants plus psychological therapy versus psychological therapy alone for substance misuse.

6.4.1.2.1. Support and educational interventions
Psychoeducation versus control or treatment as usual (TAU)

One RCT (N=60) met the eligibility criteria for this review: Brown 1980 (Brown, 1980).

An overview of the trial can be found in

Table 90. Further information about both included and excluded studies can be found in Appendix L.

Summary of findings can be found in N= total number of participants;

1 Number randomised

Table 91. The full evidence profiles and associated forest plots can be found in Appendices N and O, respectively.

The RCT had 3 arms with service users being allocated to either psychoeducation, educational drinking (where participants learned to control their drinking behaviour in an experimental bar facility) or treatment as usual. Only the psychoeducation and treatment as usual arms are included here. The psychoeducational intervention consisted of 3-hour sessions comprising a 30 minute talk, a 30 minute film and then a chaired group discussion. The types of topic covered included drinking and driving, effects of alcohol on physical health, effects upon family and how to modify drinking habits. Treatment as usual consisted of assigned tasks at the periodic detention centre.

The available data for this review was of very low quality. No data were available for the outcomes of offending or reoffending, adaptive functioning, service utilisation or rates of self-injury.

Table 90. Study information table for trials included in the analysis of psychoeducation versus control or treatment as usual for drug misuse.

Table 90

Study information table for trials included in the analysis of psychoeducation versus control or treatment as usual for drug misuse.

Table 91. Summary of findings table for psychoeducation versus control or treatment as usual for drug misuse.

Table 91

Summary of findings table for psychoeducation versus control or treatment as usual for drug misuse.

Employment workshop versus control or treatment as usual for substance misuse

Two RCTs (N=555) met the eligibility criteria for this review: Hall 1981 (Hall et al., 1981) and Webster 2014 (Webster et al., 2014).

An overview of the trials can be found in

Table 92. Further information about both included and excluded studies can be found in Appendix L.

Summary of findings can be found in N= total number of participants;

1 Number randomised

Table 93. The full evidence profiles and associated forest plots can be found in Appendices N and O, respectively.

Both studies were 2-armed trials conducted in the community. The experimental arm of both trials (employment workshop) consisted of a mixture of individual and group sessions designed to provide information, support and opportunities to practice skills needed to find and maintain employment and seek promotion. The control arm of the Hall 1981 study consisted of a 3-hour sign-posting meeting. The control arm of the Webster 2014 study consisted of treatment as usual. Although “treatment as usual” was not specified, it was assumed that the control group in Webster 2014, are likely to have had access to substance misuse support or treatment at least as effective as the control group’s 3-hour meeting in the Hall 1981 study. Thus, the outcomes were combined in the analyses.

The evidence for this review was of low to very low quality. No data were available for the outcomes of mental health, offending and reoffending, service utilisation or rates of self-injury.

Table 92. Study information table for trials included in the analysis of employment workshop versus control or treatment as usual for substance misuse.

Table 92

Study information table for trials included in the analysis of employment workshop versus control or treatment as usual for substance misuse.

Table 93. Summary of findings table for employment workshop versus control or treatment as usual for substance misuse.

Table 93

Summary of findings table for employment workshop versus control or treatment as usual for substance misuse.

6.4.1.2.2. Physical interventions
Acupuncture versus active intervention

Two RCTs (N=726) met the eligibility criteria for this review: Berman 2004 (Berman et al., 2004) and Konefal 1995 (Konefal et al., 1995).

An overview of the trials can be found in

Table 94. Further information about both included and excluded studies can be found in Appendix L.

Summary of findings can be found in N= total number of participants;

1 Number randomised

Table 95. The full evidence profiles and associated forest plots can be found in Appendices N and O, respectively.

Both studies were 2-armed trials. The Berman 2004 study compared two different forms of acupuncture, the NADA (National Acupuncture Detoxification Association) and the Helix protocols. This study was conducted within a prison setting. In the Konefal 1995 study service users in one arm received acupuncture in addition to frequent urine testing and in the other frequent urine testing only. This study was conducted in the community. Both studies used the NADA protocol for acupuncture in the intervention arm. The NADA protocol consists of 5 points chosen for their ability to assist with detoxification; Shen-Men, sympathetic, kidney, liver and lung. The Helix protocol involved acupuncture to the ear using five points on the helix of the ear

The evidence for this review was low to very low quality. No data were available for the outcomes of offending or reoffending, adaptive functioning or rates of self-injury.

Table 94. Study information table for trials included in the analysis of acupuncture versus active intervention for substance misuse.

Table 94

Study information table for trials included in the analysis of acupuncture versus active intervention for substance misuse.

Table 95. Summary of findings table for acupuncture versus active intervention for substance misuse.

Table 95

Summary of findings table for acupuncture versus active intervention for substance misuse.

6.4.1.3. Depression

Three RCTs (N = 206) met the eligibility criteria for this review: Gussak 2009, Johnson 2012 and Wilson 1990 (Gussak, 2008; Johnson & Zlotnick, 2012; Wilson, 1990). Gussak 2009 was arts-based psychotherapy (examples included construction of three-dimensional forms with few supplies); Johnson 2012 used interpersonal psychotherapy (IPT) intervention compared to psychoeducation whereas Wilson 1990 compared group cognitive treatment with individual supportive therapy. Due to the differences in the psychotherapy interventions data were not combined and separate analysis was done and presented for each study. In Johnson 2012, IPT was based on Wilfrey 2000 psychotherapy model while in Wilson 1990, group therapy was based on Hollon and Shaw 1979 cognitive treatment model.

An overview of the trials included in the meta-analysis can be found in

Table 96. Further information about both included and excluded studies can be found in Appendix L.

Summary of findings can be found in N= total number of participants

1 Number randomised

Table 97. The full GRADE evidence profiles and associated forest plots can be found in Appendices N and O, respectively.

No data were available for the outcomes of offending and reoffending, service utilization, adaptive functioning and rates of self-injury.

Table 96. Study information table for trials included in the meta-analysis of psychotherapy for depression.

Table 96

Study information table for trials included in the meta-analysis of psychotherapy for depression.

Table 97. Summary of findings table of psychological intervention versus active intervention or no treatment for depression.

Table 97

Summary of findings table of psychological intervention versus active intervention or no treatment for depression.

6.4.1.4. Individuals with suicidal risk

One RCT (N = 46) met the eligibility criteria for this review: Biggam 2002 (Biggam & Power, 2002). Principal training techniques in social problem-solving group therapy included instruction, active discussion, reflective listening and group exercises to practice the targeted skills. It was delivered in small group format (4-6 individuals/group). The participants in control did not receive principal training techniques.

An overview of the trials included in the meta-analysis can be found in

Table 98. Further information about both included and excluded studies can be found in Appendix L.

Summary of findings can be found in N= total number of participants; NR=Not reported

1 Number randomised

Table 99. The full GRADE evidence profiles and associated forest plots can be found in Appendices N and O, respectively.

No data were available for the outcomes of offending and reoffending, service utilization, adaptive functioning and rates of self-injury.

Table 98. Study information table for trials included in the meta-analysis of social problem-solving group therapy for vulnerable personality with suicidal risks.

Table 98

Study information table for trials included in the meta-analysis of social problem-solving group therapy for vulnerable personality with suicidal risks.

Table 99. Summary of findings table of social problem-solving group therapy versus no treatment control for vulnerable personality with suicidal risks.

Table 99

Summary of findings table of social problem-solving group therapy versus no treatment control for vulnerable personality with suicidal risks.

6.4.1.5. Anxiety Disorder

One RCT (N = 38) met the eligibility criteria for this review: Maunder 2009 (Maunder et al., 2009). The therapy was based on CBT-principles. The intervention group was provided with a booklet with a list of instructions and exercises and completed the time diary and thought about their personal reactions to the booklet. The participants in control group did not receive self-help booklets.

An overview of the trials included in the meta-analysis can be found in

Table 100. Further information about both included and excluded studies can be found in Appendix L.

Summary of findings can be found in N= total number of participants; NR=Not reported

1 Number randomised

Table 101. The full GRADE evidence profiles and associated forest plots can be found in Appendices N and O, respectively.

No data were available for the outcomes of offending and reoffending, service utilization, adaptive functioning and rates of self-injury.

Table 100. Study information table for trials included in the meta-analysis of self-help materials versus wait-list control for anxiety disorders.

Table 100

Study information table for trials included in the meta-analysis of self-help materials versus wait-list control for anxiety disorders.

Table 101. Summary of findings table of self-help materials versus wait-list control for anxiety disorders.

Table 101

Summary of findings table of self-help materials versus wait-list control for anxiety disorders.

6.4.1.6. PTSD

Four RCTs (N =290) met the eligibility criteria for this review: Bradley 2003, Ford 2013, Cole 2007 and Valentine 2001 (Bradley & Follingstad, 2003; Cole et al., 2007; Ford et al., 2013; Valentine & Smith, 2001). Bradley 2003, Ford 2013 and Cole 2007 studies used group therapy method whereas Valentine 2001 applied traumatic incident reduction psychotherapy model. Bradley 2003 and Cole 2007 compared with no-contact and wait-list control respectively. Thus, outcomes were combined in analysis if they were measured by the same measurement tool. Ford 2013 study compared Trauma affect regulation: Guide for Education and Therapy (TARGET) with small group therapy (SGT). Moreover, Valentine 2001 study evaluated trauma incident reduction compared to wait-list controls. Data from these studies were analysed separately.

An overview of the trials included in the meta-analysis can be found in

Table 102. Further information about both included and excluded studies can be found in Appendix L.

Summary of findings can be found in N= total number of participants

TIR=Traumatic incident reduction

TARGET=Trauma Affect Regulation: Guide for Education and Therapy

PTSD=Post-traumatic stress disorders

1 Number randomised

Table 103. The full GRADE evidence profiles and associated forest plots can be found in Appendices N and O, respectively.

No data were available for the outcomes of offending and reoffending, service utilization, adaptive functioning and rates of self-injury.

Table 102. Study information table for trials included in the meta-analysis of psychotherapy versus no treatment/wait-list control/active treatment for post-traumatic stress disorders.

Table 102

Study information table for trials included in the meta-analysis of psychotherapy versus no treatment/wait-list control/active treatment for post-traumatic stress disorders.

Table 103. Summary of findings table of psychotherapy vs wait-list control/No treatment/Active treatment for PTSD.

Table 103

Summary of findings table of psychotherapy vs wait-list control/No treatment/Active treatment for PTSD.

6.4.1.7. ADHD

Two studies (N = 84) met the eligibility criteria for this review: Ginsberg 2012 and Konstenius 2013 (Ginsberg et al., 2012b; Ginsberg & Lindefors, 2012a; Konstenius et al., 2013). The placebo and the methylphenidate capsules and packaging were identical in appearance. Data were combined by meta-analysis as the population, type of intervention and placebo were the same.

An overview of the trials included in the meta-analysis can be found in

Table 104. Further information about both included and excluded studies can be found in Appendix L.

Summary of findings can be found in N= total number of participants;

1 Number randomised

Table 105. The full GRADE evidence profiles and associated forest plots can be found in Appendices N and O, respectively.

No data were available for the outcomes of offending and reoffending, service utilization, adaptive functioning and rates of self-injury.

Table 104. Study information table for trials included in the meta-analysis of methylphenidate versus Placebo for Attention Deficit Hyperactivity Disorder (ADHD).

Table 104

Study information table for trials included in the meta-analysis of methylphenidate versus Placebo for Attention Deficit Hyperactivity Disorder (ADHD).

Table 105. Summary of findings table for Methylphenidate versus Placebo for Attention Deficit Hyperactivity Disorder.

Table 105

Summary of findings table for Methylphenidate versus Placebo for Attention Deficit Hyperactivity Disorder.

6.4.1.8. Antisocial personality disorders

One RCT (N = 12) met the eligibility criteria for this review: Gowin 2012 (Gowin et al., 2012). This study took a total of 6 week, with no treatment in week 1, placebo to both groups in week 2, either tiagabine or placebo in week 3, 4 and 5 and placebo to both groups in week 6. Tiagabine was given orally in an escalating dose of 4, 8, 12 mg bd over 3 weeks. Outcomes were measured immediately post-treatment and during a period of follow-up

An overview of the trials included in the meta-analysis can be found in

Table 106. Further information about both included and excluded studies can be found in Appendix L. Summary of findings can be found in N= total number of participants;

1 Number randomised

Table 107. The full GRADE evidence profiles and associated forest plots can be found Appendices N and O, respectively.

No data were available for the outcomes of offending and reoffending, service utilization, adaptive functioning and rates of self-injury.

Table 106. Study information table for trials included in the meta-analysis of Tiagabine versus placebo for the antisocial personality disorder.

Table 106

Study information table for trials included in the meta-analysis of Tiagabine versus placebo for the antisocial personality disorder.

Table 107. Summary of findings table for Tiagabine versus placebo for the antisocial personality disorder.

Table 107

Summary of findings table for Tiagabine versus placebo for the antisocial personality disorder.

6.4.1.9. Severe mental illness

6.4.1.9.1. Pharmacological interventions

One RCT (N=450) met the eligibility criteria for the review: Alphs 2015a (Alphs et al., 2015). In this study, Paliperidone was given intramuscularly with 234 mg on day 1 and 158 mg on day 8 with monthly maintenance range of 78-238 mg thereafter from day 38. Patients on oral regime received aripiprazole 33 (15.1%), haloperidol 15 (6.9%), olanzapine 36 (16.5%), paliperidone 48 (22%), perphenazine 20 (9.2%), quetiapine 29 (13.3%) or risperidone 37 (17%).

An overview of the trials included in the meta-analysis can be found in

Table 108. Further information about both included and excluded studies can be found in Appendix L.

Summary of findings can be found in N= total number of participants;

1 Number randomised

Table 109. The full GRADE evidence profiles and associated forest plots can be found Appendices N and O, respectively.

No data were available for the outcomes of offending and reoffending, service utilization, adaptive functioning and rates of self-injury.

Table 108. Study information table for trials included in the meta-analysis of IM pahpendone versus oral antipsychotics for schizophrenia.

Table 108

Study information table for trials included in the meta-analysis of IM pahpendone versus oral antipsychotics for schizophrenia.

Table 109. Summary of findings table for palip Schizophrenia.

Table 109

Summary of findings table for palip Schizophrenia.

6.4.1.9.2. Psychological intervention

Two RCTs (N = 204) met the eligibility criteria for this review: Bond 2015 and Clayton 2013 (Bond et al., 2015; Clayton et al., 2013). The Bond 2015 study recruited participants with no competitive job placement in previous three months. The study used Individual Placement and Support (IPS) model, supported by employment specialist and the aim was to help identify and prepare for job search. On the other hand, the Clayton 2013 study included participants with severe mental illness who had a criminal charge in the 2 years prior to enrolment for the Citizenship project. The project consisted of three integrated components: individual peer mentor support (8 hours/week), an 8-week citizenship class and an 8-week valued role component. The separate analysis was performed for different intervention.

An overview of the trials included in the analysis can be found in Table 110. Further information about both included and excluded studies can be found in Appendix L.

Summary of findings can be found in Table 111 and Table 112. The full GRADE evidence profiles and associated forest plots can be found in Appendices N and O, respectively.

No data were available for the outcomes of service utilization and rates of self-injury.

Table 110. Study information table for trials included in the analysis of psychosocial intervention versus treatment as usual for severe mental illness.

Table 110

Study information table for trials included in the analysis of psychosocial intervention versus treatment as usual for severe mental illness.

Table 111. Summary of findings table for the Citizenship Project versus TAU for Severe Mental Health Disorders.

Table 111

Summary of findings table for the Citizenship Project versus TAU for Severe Mental Health Disorders.

Table 112. Summary of findings table for Individual Placement and Support (IPS) vs Work choice models for severe mental illness.

Table 112

Summary of findings table for Individual Placement and Support (IPS) vs Work choice models for severe mental illness.

6.4.1.10. Interventions for uncategorized mental health disorders

6.4.1.10.1. Parenting from the inside

One RCT (N=176) met the eligibility criteria for this review: Loper 2011 (Loper, 2011). The intervention was based on cognitive behavioural strategy and the sessions were focused on connecting with one’s own children emotionally and guiding as a parent, while they were in prison.

An overview of the trials included in the meta-analysis can be found in

Table 113. Further information about both included and excluded studies can be found in Appendix L. N= total number of participants;

1 Number randomised

Table 114. The full GRADE evidence profiles and associated forest plots can be found in Appendices N and O, respectively.

No data were available for the outcomes of offending and reoffending, service utilization, adaptive functioning and rates of self-injury.

Table 113. Study information table for trials included in the analysis of parenting from inside versus wait-list control for mental health disorders.

Table 113

Study information table for trials included in the analysis of parenting from inside versus wait-list control for mental health disorders.

Table 114. Summary of findings table for parenting from inside vs Wait-list control for mental health disorders.

Table 114

Summary of findings table for parenting from inside vs Wait-list control for mental health disorders.

6.4.1.10.2. Music Therapy

Two RCTs (N = 215) met the eligibility criteria for this review: Chen 2015 and Hakvoort 2013 (Chen et al., 2015; Hakvoort et al., 2013). The two studies used standard care and wait-list control as comparison respectively and the underlying mental health disorders and the reported mental outcome measures were also different. Thus, separate analysis was performed for each study.

An overview of the trials included in the meta-analysis can be found in Table 115. Further information about both included and excluded studies can be found in Appendix L.

Summary of findings can be found in N= total number of participants;

1 Number randomised

Table 116 and 1 Chen 2015 - Appropriate randomization with proper concealment; blinding of care administrators, but not participants; ITT analysis; appropriate outcome report

Table 117. The full GRADE evidence profiles and associated forest plots can be found in Appendices N and O, respectively.

No data were available for the outcomes of offending and reoffending, service utilization, adaptive functioning and rates of self-injury.

Table 115. Study information table for trials included in the analysis of music therapy versus standard care or wait-list control for mental health disorders.

Table 115

Study information table for trials included in the analysis of music therapy versus standard care or wait-list control for mental health disorders.

Table 116. Summary of findings table for music therapy vs standard care for depression and anxiety disorders.

Table 116

Summary of findings table for music therapy vs standard care for depression and anxiety disorders.

Table 117. Summary of findings table for music therapy vs wait-list control for antisocial personality disorders.

Table 117

Summary of findings table for music therapy vs wait-list control for antisocial personality disorders.

6.4.2. Economic evidence

6.4.2.1. Systematic literature review

The systematic search of the literature identified 3 studies that assessed the costs and benefits of interventions for adults with substance misuse disorders who are in contact with the criminal justice system.

Of these:

No studies assessing the cost effectiveness of psychological, social, pharmacological or physical interventions for other disorders recommended in existing NICE guidance for adults who are in contact with the criminal justice system, were identified by the systematic search of the economic literature undertaken for this guideline. Details on the methods used for the systematic review of the economic literature are described in Chapter 3; full references and evidence tables for all economic evaluations included in the systematic literature review are provided in Appendix S. Completed methodology checklists of the studies are provided in Appendix R. Economic evidence profiles of studies considered during guideline development (that is, studies that fully or partly met the applicability and quality criteria) are presented in Appendix T.

6.4.2.2. Psychosocial interventions

6.4.2.2.1. Daley and colleagues (2004)

Daley and colleagues (2004) evaluated the cost effectiveness of a prison-based substance abuse treatment for incarcerated adult offenders with a substance abuse problem in the US, Connecticut. Four tiers of the substance abuse intervention were assessed: ‘Tier 1’ intervention involved one weekly session of drug/alcohol education for up to 6 group sessions, ‘Tier 2’ intervention involved 30 outpatient group sessions 3 days a week for 10 weeks, ‘Tier 3’ intervention involved intensive day treatment programme consisting of 4 sessions a week for 4 months or a total of 64 sessions and ‘Tier 4’ intervention comprised of a residential treatment programme consisting of full-time daily treatment for 6 months in a separate housing unit. Different tiers were compared to each other and also to no intervention alternative. The economic analysis was based on an observational cohort study (N=831). Clinical effectiveness data were derived from the observational study participants. The time horizon of the economic analysis was 1 year and its perspective was the taxpayer. Cost elements comprised intervention costs, including substance abuse and mental health treatment. Cost data were collected for the study participants from interlinked administrative records and databases, accounting data and, as necessary, were supplemented with authors’ assumptions. The primary measure of outcome utilised in the economic analysis was the likelihood of re-arrest. Regression analysis was used to adjust outcomes for baseline differences in service user characteristics including race, age, drug need score, security risk, prior arrests and other programs attended.

The mean cost per participant over 1 year was $0 for no intervention group, $189 for ‘Tier 1’ group, $672 for ‘Tier 2’ group, $2,677 for ‘Tier 3’ group and $5,699 for ‘Tier 4’ group (in likely 2003 US dollars). The adjusted probability for re-arrest with one year post-release was 45.9% for no intervention, 49.3% for ‘Tier 1’ group, 37.4% for ‘Tier 2’ group, 27.2% for ‘Tier 3’ group and 23.5% for ‘Tier 4’ group. In terms of cost effectiveness and under a public sector perspective ‘Tier 1’ intervention was dominated by no intervention group (that is, it was less effective and more costly). The ICER for ‘Tier 2’ intervention versus no intervention was $7,906 per re-arrest avoided; for ‘Tier 3’ versus ‘Tier 2’ it was $19,657 and for ‘Tier 4’ versus ‘Tier 3’ it was $81,676.

The study is only partially applicable to the NICE decision-making context, as it has been conducted in the US and adopted a narrow healthcare payer perspective and has not considered wider social care costs. The measure of outcomes was not expressed in QALYs, which made interpretation of findings difficult. The study was judged by the GC to have potentially serious methodological limitations, including the relatively short time horizon (1 year), the lack of consideration of health outcomes, the study design (observational study) and source of unit cost data was unclear.

6.4.2.3. Pharmacological interventions

6.4.2.3.1. Gisev and colleagues (2015)

Gisev and colleagues (2015) evaluated the cost effectiveness of opioid substitution therapy (OST) upon prison release in New South Wales, Australia. OST treatment was compared with no OST treatment at prison release. The economic analysis was based on a retrospective matched-control study, using records of OST entrants, charges and court appearances, prison episodes and death notifications. A total of 13,468 individuals were matched (N=6,734 in each group). The time horizon of the economic analysis was 6 months post-release and its perspective was the public sector (healthcare and criminal justice system). Cost elements comprised treatment, criminal justice system (court, penalties, prison) and the social costs of crime. It is unclear what social costs of crime are. However, they are likely to include physical injury, psychological trauma, a feeling of vulnerability and a fear of crime. The primary measure of outcome utilised in the economic analysis was the mortality rate.

The mean bootstrapped cost per participant at 6 months was $7,206 for OST group and $14, 356 for no treatment group; a difference of −$6,353 (95% CI: −$7,568; −$5,139) (in 2012 AUD). The bootstrapped mortality rate at 6 months was 0.3% for the OST group and 0.7% for the no treatment group; a difference of −0.4% (level of statistical significance not reported). Based on the above findings OST treatment is dominant when compared with no intervention alternative. According to the cost effectiveness acceptability curve, the probability that OST post-release treatment is cost-effective is 96.7% at a willingness to pay of $500 per life saved. The results of the sensitivity analyses highlighted the robustness of the findings to the changes in the assumptions pertaining to the criminal justice system costs (for example, scenario where all 6-month costs were attributed to crime and excluding prison costs altogether)

The study is only partially applicable to the NICE decision-making context, as it has been conducted in Australia. The measure of outcome was not expressed in QALYs. However, the intervention was found to be dominant. The study was judged by the GC to have potentially serious methodological limitations, including the relatively short time horizon (6 months), the study design (retrospective matched-control study), the lack of consideration of mental health outcomes and the derivation of unit cost data from a mixture of national and local sources.

6.4.2.3.2. Warren and colleagues (2006)

Warren and colleagues (2006) evaluated the cost effectiveness of a prison methadone programme provided in the context of other prison health services, including counselling and related non-pharmacotherapy treatment services versus SC (no prison-based methadone intervention) in New South Wales, Australia. This was an economic modelling study with effectiveness data obtained from an RCT (N=405). The time horizon of the economic analysis was 1 year and its perspective was a prison service provider. Cost elements comprised programme provision, including enrolment of prisoners on the programme, provision of daily methadone and associated treatment and referral of prisoners who exit the programme to other services. Cost data were obtained from an RCT, administrative databases and published sources. The primary measures of outcome utilised in the economic analysis were the days of heroin use, deaths prevented due to substance abuse and hepatitis C (HCV) cases avoided or delayed.

According to the analysis the intervention resulted in a mean annual cost of $3,234 per participant in 2003 Australian dollars. SC was assigned the cost of $0 in the analysis. In terms of effectiveness the number of days of heroin use in a year was 15 and 100 in the intervention and SC group, respectively; a difference of −85 days. It was also found that the annual mortality difference was −0.71% between those receiving prison-based methadone treatment and those not receiving methadone and that provision of prison methadone for a year reduced the incidence of HCV by 0.08 cases.

Based on the above findings the ICER associated with the intervention was $38 per additional heroin free day, $458,074 per additional death avoided and $40,428 per HCV case avoided. The authors concluded that in-prison methadone was no more costly than community methadone and provided benefits in terms of reduced heroin use in prisons, with associated reduction in morbidity and mortality (Warren et al., 2006). The GC could not judge the cost effectiveness of prison-based methadone treatment due to the lack of QALYs.

The study is only partially applicable to the NICE decision-making context, as it has been conducted in Australia and adopted a narrow prison service provider perspective (only intervention costs were reported). The measure of outcomes was not expressed in QALYs, which made interpretation of the findings difficult. The study was judged by the GC to have potentially serious methodological limitations, including the relatively short time horizon (1 year), the fact that some of the model inputs were based on authors’ assumptions (resource use), the lack of consideration of social care and criminal justice sector costs, limited sensitivity analysis and also the source of unit cost data was unclear.

6.4.3. Clinical evidence statements

6.4.3.1. Substance misuse

6.4.3.1.1. Psychological interventions

Low quality evidence from 1 RCT (N=95) suggested a clinically important difference between CBT alone and CBT plus contingency management in number of days with cannabis positive urine test, although there was no difference in number of self-reported days with cannabis use between the two groups.

Very low quality evidence from 1 RCT (N=75) indicated uncertainty about the relative effectiveness of CBT and a 12-step program in terms of number of days with either positive urine test or positive breath analyser test. The same RCT (N=71) indicated a clinically important difference for an increase in number of days abstinent from alcohol with CBT therapy as relative to 12-step program although the effect was non-significant for number of days abstinent from drugs between the two groups.

Very low quality evidence from 1 RCT (N=44) suggested no clinically significant difference between CBT therapy and seeking safety for ASI-6 alcohol or drug composite scores, number of abstinent weeks. Although repeat incarceration rates were reduced by almost half with CBT, there was considerable uncertainty in the effect estimate.

Very low quality data from 1 RCT (N=27) showed no clinically important difference between CBT and wait-list control for ASI-6 alcohol composite score and uncertainty about their relative effectiveness in terms of drug composite scores and abstinence in the previous 3 months.

Very low to low quality evidence from 1 RCT (N=30) showed a clinically important reduction in ASI-6 alcohol composite score with acceptance and commitment therapy as compared to CBT therapy although the effect was not clinically significant for ASI-6 drug composite scores. The same RCT suggested uncertainty about their relative effectiveness in terms of abstinence from drugs.

Very low quality evidence from 2 RCTs showed uncertainty about the relative effectiveness of acceptance and commitment therapy and wait-list control in terms of ASI-6 alcohol (N=56) and drug (N=52) composite scores. Similarly, one RCT of low quality (N=25) reported uncertainty about the relative effectiveness of the two groups in terms of abstinence from drugs.

Very low quality data from 1 RCT (N=54) showed no clinically significant difference between mindfulness-based relapse prevention (MBRP) and cognitive behavioural therapy (CBT) for number of drug use days and short inventory problems (SIP) scores at follow-up. The same RCT also suggested a clinically important effect of MBRP for reduction of legal composite and medical composite scores of ASI as relative to CBT, the effect was not clinically significant for family-social composite and psychiatric composite scores.

Very low to low quality evidence suggested no clinically important difference between contingency management and counselling for self-reported days (2 RCTs; N=263) or urine test positive (1 RCT; N=136) for cannabis use during treatment.

Similarly, very low quality evidence of 1 RCT (N=65) reported no significant difference in ASI-marijuana scores at post-treatment and follow-up between contingency management and motivational enhancement therapy. Although the same study suggested a clinically important difference for an increase in number of cannabis use days per month at post-treatment with contingency management as relative to motivational enhancement therapy, the effect was uncertain at follow-up.

Very low quality evidence from 1 RCT (N=165) suggested uncertainty about the effectiveness of contingency management compared to psychoeducation in terms of number of participants still in treatment and number of days in treatment at follow-up.

Low quality evidence from 1 RCT (N=20) indicated uncertainty about the effectiveness of contingency compared to treatment as usual in terms of arrests for public drunkenness.

Very low quality data from 1 RCT showed clinically significant effect of motivational enhancement for an increase in percentage of self-reported days abstinent from alcohol or alcohol and drug as relative to psychoeducation at 3-months follow-up (N=238), but the effect was non-significant at 6-months (N=214) and 12-months (N=190) follow-up. Moreover, the same RCT also suggested no important difference between motivational enhancement therapy and psychoeducation for number of drinks per drinking days at 3-months (N=238), 6-months (N=214) and 12-months (N=190) follow-up.

Very low quality evidence from 1 RCT (N=136) suggested a clinically important difference between motivational enhancement therapy and CBT plus contingency management for percentage of cannabis positive urine test use during treatment although the effect was uncertain for percentage of cannabis use days.

Very low quality evidence from 1 RCT (N=27) suggested no clinical effect between motivational enhancement and CBT plus contingency management for self-reported motivation to take steps to change substance misuse scores.

Very low quality evidence from 1 RCT (N=79) suggested uncertainty about the difference in drug positive urine test (during treatment), self-reported drug or alcohol use (at 1-month follow-up) between motivational interviewing therapy and no treatment controls.

Very low quality evidence from 1 RCT (N=114) indicated no clinically significant difference between motivational interviewing and usual planning interviewing for number of self-reported days with drug use and number of days with illegal activity in past 30 days at 10 month follow-up.

Low quality evidence from 1 RCT reported uncertainty about the difference in number of drop-outs from subsequent treatment among either binge drinking group (N=23) or no binge drinking group (N=35) between motivational interviewing and no treatment control. The same RCT also suggested a clinically significant increase in the number of subsequent treatment sessions attended among binge drinking groups as relative to no treatment control although the difference was non-significant among no binge drinking group.

Very low quality evidence from 1 RCT (N=30) suggested uncertainty about the effectiveness of assessment with motivational feedback and assessment without feedback in terms of rates of speciality addiction clinic attendance.

Very low quality evidence from 1 RCT (N=128) suggested uncertainty about the relative effectiveness of group counselling and treatment as usual in terms of re-arrest, number of re-convictions (N=149), re-incarceration and number of incarcerated days (N=149) at 12-months follow-up. The same RCT of very low quality reported that although there was clinical significant difference for reduction in self-reported marijuana use with group counselling compared to treatment as usual, the effect was uncertain for self-reported LSD use, self-reported speed use and self-reported heroin use at 12-months follow-up.

Low quality evidence from 1 RCT (N=183) showed a clinically important difference between self-help journal and no intervention with fewer subsequent bookings at 12-month follow-up in the self-help group.

6.4.3.1.2. Pharmacological interventions

Very low quality evidence from 1 RCT showed uncertainty about the effectiveness of naloxone compared to placebo for number of participants with discontinued medication (N=97) and number of positive urine tests whilst still engaged with treatment (N=163).

Very low to moderate quality evidence from 1 RCT (N=51) showed uncertainty about the effectiveness of naltrexone compared to placebo for number of participants who retained in treatment as well as number of participants with positive urine test for alcohol, amphetamine, benzodiazepine, cocaine, marijuana or opiates while still engaged with treatment.

Very low quality evidence showed uncertainty about the effectiveness of naltrexone compared to placebo for cocaine use (N=63) and injection drug use (N=308) at post-treatment. However, very low quality evidence from 2 RCTs (N=371) suggested a clinically important reduction in opioid use with naltrexone treatment compared to placebo at post-treatment.

Low quality evidence from 1 RCT (N=44) reported uncertainty about the effectiveness of naltrexone compared to placebo in terms of number of days amphetamine, benzodiazepine or heroin use per month at 6-months follow-up.

Low to very low quality evidence indicated uncertainty about the effectiveness of naltrexone compared to placebo in terms of re-incarceration during treatment (1 RCT; N=51), post-treatment (1 RCT; N=308) and re-incarceration (1 RCT; N=44) in comparison with placebo.

One RCT of very low quality (N=63) suggested a clinically important reduction in parole violations with naltrexone compared to placebo at post-treatment although there was no difference in drug charges between the two groups. One RCT (N=44) of very low quality uncertainty about the effectiveness of naltrexone compared to placebo in terms of number of days of criminal activity per month at 6 month follow-up.

Low quality evidence from 1 RCT (N=308) reported a clinically important increase in the number of participants experiencing an adverse event at 1-year follow-up with naltrexone treatment when compared to placebo. However, there was uncertainty about the relative rates of death and non-fatal overdoses between the two groups at 1-year follow-up.

Low quality evidence from one RCT (N=382) suggested a clinically important increase in drop-outs with methadone compared to the waiting list control group.

Very low quality evidence suggested clinically important difference between methadone and control for opioid positive test at 1-month follow-up (1 RCT; N=197) and 3-months follow-up (2 RCTs; N=444). However, there was uncertainty about the differences at post-treatment (2 RCTs; N=547), 2-months follow-up (1 RCT; N=207) and 4-months follow-up (2 RCTs; N=538).

Very low quality evidence from one RCT (N=196) and moderate quality evidence from another RCT (N=382) suggested no clinically important difference between methadone and control for re-incarceration at 1-month follow-up and 4-years follow-up respectively.

Very low quality evidence from one RCT suggested uncertainty about the difference between methadone and controls for deaths (N=223) and non-fatal overdoses (N=196).

Low quality evidence from 1 RCT (N=63) showed no clinically important difference between alpha-adrenergic agonists and opioid maintenance for total withdrawal symptoms at post-treatment.

Very low to low quality evidence suggested uncertainty about the effectiveness of opioid substitution therapy compared to active intervention or placebo in terms of number of dropouts (2 RCTs; N=206), abstinence at post-treatment (1 RCT; N=213), at 1-month follow-up (1 RCT; N=159), 3-months follow-up (1 RCT; N=94) and 6-months follow-up (2 RCTs; N=150), opioid abuse at 3-months follow-up (1 RCT; N=116), self-reported injection drug use at post-treatment and 3-month follow-up (1 RCT; N=36) as well as number of times re-arrested at 3-months follow-up, re-arrest for drug crimes at 3-months follow-up and re-incarceration at post-treatment (1 RCT; N=116).

6.4.3.1.3. Combined psychological and pharmacological interventions

Low quality evidence from 1 RCT (N=60) indicated uncertainty about the effectiveness of fluoxetine plus psychological therapy (CBT and motivational therapy) compared to psychological therapy alone in terms of the number of participants who failed to complete treatment. The same RCT also suggested a clinically important decrease in Hamilton depression rating scores with fluoxetine plus psychological therapy as relative to psychological therapy alone although there was no clinically important difference in Spielberger state anxiety inventory scores between the two groups.

6.4.3.1.4. Support and education interventions

Very low quality evidence from 1 RCT (N=34) showed that compared with treatment as usual, psychoeducation had uncertain effects on the number of days of uncontrolled drinking.

Low to very low quality evidence indicated uncertainty about the effectiveness of an employment workshop compared to treatment as usual in terms of the number of participants employed (2 RCTs; N=529) and number of days in paid employment (1 RCT; N=477).

6.4.3.1.5. Physical interventions

One RCT of low quality (N=158) suggested a clinically important increase in drop-out rates with acupuncture as compared to helix control (placebo acupuncture) whereas very low quality evidence from 2 RCTs (N=108) reported uncertainty about the relative effectiveness of acupuncture and other active interventions for substance misuse in terms of drug-positive urine test at post-treatment between.

6.4.3.2. Depression

Very low quality evidence from one RCT (N=38) indicated interpersonal psychotherapy had a clinically important effect on depression by HRSD scales at post-treatment when compared to a psychoeducation intervention, but this effect was uncertain at 13-weeks follow-up.

Very low quality evidence from one RCT (N=10) indicated uncertainty about the effectiveness of group cognitive treatment compared to individual support therapy in terms of depression by BDI scales, Hopeless scales, MMPI D scales and Multiple affect adjective checklist D scales at post-treatment and in depression symptoms by MMPI D scales at 39-weeks follow-up.

Very low quality evidence from one randomized study (N=158) showed that arts-based therapy had a clinically significant effect on Adult Nowicki-Strickland Locus (ANS) of control scale and depression scales by BDI in male, female and combined groups in comparison with no treatment control. Low quality evidence from this trial indicated arts-based therapy had a clinically significant effect on two of the formal elements of the arts therapy scale rating guide (FEATS), prominence of colour and colour fit when compared to no treatment control.

6.4.3.3. Vulnerable inmates with suicidal risk

One randomized study (N=46) provided very low quality evidence of a clinically significant beneficial effect of a social problem solving group on depression symptoms by either HADS or Beck Hopeless scales at post-treatment and 13-weeks follow-up compared to no treatment control. Similarly, it is clinically significant that the social group therapy decreased anxiety symptoms by HADS scales at post-treatment and 13-weeks follow-up. Low quality evidence from this trial indicated decision making ability as measured by SPSI:R scales was improved by a clinically significant amount in the social problem solving group therapy compared to the no treatment control group.

6.4.3.4. Anxiety Disorders

Very low quality evidence from one randomized study (N=33) indicated uncertainty about the effectiveness of psychological therapy with self-help compared to wait-list control in terms of anxiety symptoms by HADS scales at post-treatment. This trial, however, reported a clinically significant reduction in anxiety with the self-help materials compared to wait-list control after 4-weeks of follow-up.

6.4.3.5. PTSD

Very low quality evidence from two randomized studies (N=40) indicated uncertainty about the effectiveness of psychological therapy (group method) compared to wait-list or no-contact control in terms of trauma symptoms by TSI scales.

Very low quality evidence from one RCT (N=123) reported a clinically significant decrease in depression symptoms by BDI scale and PTSD symptoms by PSS scales at either post-treatment or 13-weeks follow-up, increase in post-treatment generalised expectancy for success scales as well as increase in 13-weeks follow-up clinical anxiety scales with TIR intervention relative to wait-list control. The clinical effects on generalised expectancy for success scales at 13-weeks follow-up and clinical anxiety scales at post-treatment were uncertain and of very low quality.

One RCT provided moderate quality evidence of uncertainty about the effectiveness of TARGET intervention compared to SGT intervention in terms of post-treatment PTSD symptoms by CAPS scales (N=72) and Heartland forgiveness scales (N=32; low quality evidence).

Very low to low quality evidence from one randomized study (N=9) suggested a clinically important beneficial effect of focused group therapy on global severity index, positive symptom distress index and total positive symptom index by symptom checklist-90R compared to wait-list control at post-treatment.

Very low quality evidence from one RCT (N=31) indicated uncertainty about the effectiveness of group therapy compared to no contact control in terms of IIP-32 scales.

6.4.3.6. ADHD

Very low quality evidence from two RCTs (N=84) suggested a clinically important effect of methylphenidate on reduction in ADHD symptoms by CAARS:OSV scales at post-treatment as compared to placebo. Low quality evidence from one RCT (N=20) indicated a clinically significant reduction in ADHD symptoms at 3-years follow-up with methylphenidate compared to placebo.

Very low quality evidence from one RCT (N=54) indicated uncertainty about the effectiveness of methylphenidate compared to placebo in terms of the number of participants with drug negative urine at post-treatment.

6.4.3.7. Antisocial personality disorder

Very low quality evidence from one randomized study (N=12) indicated a clinically significant decrease in aggressive response with tiagabine compared to placebo at post-treatment.

However, there was uncertainty about difference in the number of adverse effects in the two groups.

6.4.3.8. Severe mental illness

6.4.3.8.1. Pharmacological intervention

Very low quality evidence from one RCT (N=445) suggested a clinically significant reduction in first-time treatment failure rate with IM paliperidone compared to oral antipsychotics. There was low quality evidence of a clinically significant increase in the risk of prolactin-related side-effects, however, with IM paliperidone.

6.4.3.8.2. Psychosocial intervention

Low to very low quality evidence from one RCT (N=114) of uncertainty about the effectiveness of the Citizenship Project compared to TAU in terms of quality of life, number of convictions and addiction severity at post-treatment. Low quality evidence form this trial indicated a clinically significant difference between the groups in terms of alcohol composite score and withdrawal symptoms at post-treatment.

Low quality evidence from one RCT (N=85) indicated that the participants in the IPS intervention group were more than four times more likely to get competitive job placement than work choice group. However, there was uncertainty about the relative effectiveness of IPS and work choice in terms of the number of hospitalizations and number of days in hospital Interventions for uncategorized mental health disorders

6.4.3.8.3. Parenting from the inside

Very low to low quality evidence from one randomized study (N=136) indicated no clinically significant difference between parenting from inside intervention and treatment as usual for parenting stress index, parenting alliance and total brief symptom inventory scales.

6.4.3.8.4. Music therapy

Moderate quality evidence from one randomised study (N=184) suggested that music therapy had a clinically significant effect compared to standard care decreasing anxiety symptoms on state and trait anxiety measures compared to standard care. Music therapy increased self-esteem as measured by the Rosenberg self-esteem inventory and social behaviour as measured by the Texas social behaviour inventory by clinically significant amounts.

Very low to low quality evidence from one randomised study (N=13) indicated uncertainty about the effectiveness of music therapy compared to wait-list control in terms of self-management psychiatric symptoms, self-management assaultive symptoms, interpersonal skills, social dysfunction and aggression. However, very low quality evidence from this trial indicated a clinically important increase in positive coping skills as measured by FP40 scales in the music therapy group.

6.4.4. Economic evidence statements

There was evidence from 1 US study on the cost effectiveness of psychosocial prison-based interventions for people with substance abuse problems. The cost effectiveness analysis was based on an observational cohort study (N=831). It was found that intensive outpatient group treatment (3 days a week for 10 weeks) results in an ICER of $7,906 per re-arrest avoided (when compared with ‘no intervention’ option) and intensive day treatment programme (consisting of 4 sessions a week for 4 months or a total of 64 sessions) results in an ICER of $19,657 (when compared with an outpatient group treatment). This evidence was US-based and is only partially applicable to the NICE decision making-context and is characterised by potentially serious methodological limitations, including the relatively short time horizon (1 year), the lack of consideration of health outcomes, the study design (observational study) and source of unit cost data was unclear. Due to the lack of QALYs the GC could not judge the cost-effectiveness of psychosocial prison-based interventions in adult offenders with substance abuse problems.

There was mixed evidence from 2 Australian studies on the cost effectiveness of pharmacological treatments for substance abuse problems in incarcerated adult offenders. One cost-effectiveness analysis based on a retrospective observational matched-control study (N=13,468) found opioid substitution therapy (OST) upon prison release to be dominant when compared to no OST treatment. It resulted in cost savings from a public sector perspective and fewer deaths at 6 month follow-up. Another cost-effectiveness analysis based on economic modelling (with effectiveness data from an RCT) found that prison-based methadone programme provided in the context of other prison health services, including counselling and related non-pharmacotherapy treatment services (when compared with no prison-based methadone intervention) resulted in the ICERs of: $38 per additional heroin free day, $458,074 per additional death avoided and $40,428 per additional hepatitis C case avoided. This evidence is from Australian studies and is only partially applicable to the NICE decision-making context. Outcomes were not reported in the form of QALYs, which made judgements on cost effectiveness difficult, although in one of the studies judgement on cost effectiveness was straightforward since the intervention was found to be dominant. Both studies are characterised by potentially serious limitations, 1 study adopted retrospective matched-control study design, relatively short time horizons (6 months and 1 year) and lack of use of national unit costs.

6.5. Recommendations and link to evidence

Recommendations
36.

Use this guideline with any NICE guidelines on specific mental health problemsh. Take into account:

  • the nature and severity of any mental health problem
  • the presence of a learning disability or any acquired cognitive impairment
  • other communication difficulties (for example, language, literacy, information processing or sensory deficit)
  • the nature of any coexisting mental health problems (including substance misuse)
  • limitations on prescribing and administering medicine (for example, in-possession medicine) or the timing of the delivery of interventions in certain settings (for example, prison)
  • the development of trust in an environment where health and care staff may be held in suspicion
  • any cultural and ethnic differences in beliefs about mental health problems
  • any differences in presentation of mental health problems
  • the setting in which the assessment or treatment takes place.

37.

Refer to relevant NICE guidance for the psychological treatment of mental health problems for adults in contact with the criminal justice system, taking into account the need:

  • to modify the delivery of psychological interventions in the criminal justice system
  • to ensure continuity of the psychological intervention (for example, transfer between prison settings or on release from prison)
  • for staff to be trained and competent in the interventions they are delivering
  • for supervision
  • for audit using routinely available outcome measures.

38.

Practitioners should consider using contingency management to reduce drug misuse and promote engagement with services for people with substance misuse problems.

39.

Practitioners delivering contingency management programmes should:

  • agree with the person the behaviour that is the target of change
  • provide incentives in a timely and consistent manner
  • confirm the person understands the relationship between the treatment goal and the incentive schedule
  • make incentives reinforcing and supportive of a healthy and drug-free lifestyle.

40.

Refer to relevant NICE guidance for pharmacological interventions for mental health problems in adults in contact with the criminal justice system. Take into account:

  • risks associated with in-possession medicines
  • administration times for medication
  • availability of medicines in the first 48 hours of transfer to prison
  • availability of medicines after release from prison.

41.

Refer to NICE’s guidance on attention deficit hyperactivity disorder (ADHD) when prescribing pharmacological interventions for this condition.

42.

Review all medicines prescribed for sleep problems and the management of chronic pain to:

  • establish the best course of treatment (seek specialist advice if needed)
  • assess the risk of diversion or misuse of medicines.

Relative values of different outcomesThe GC were mindful that the primary aim of the interventions covered in this review question was to improve substance misuse and mental health outcomes. Therefore remission (and relapse and its prevention for those who had remitted) from the disorder and improvement in symptomatology were seen as critical outcomes. The GC were also mindful of the link between mental health problems and offending (e.g. as may be the case in substance misuse) and so also considered offending as a potentially important outcome. Given the challenge of engaging individuals in contact with the criminal justice system in treatment this was also considered.
Trade-off between clinical benefits and harmsIn assessing the trade-off between benefits and harms in the interventions covered in this protocol the GC were particularly interested in any evidence for an intervention that was specifically developed for use in the criminal justice system that demonstrated a benefit greater than might be expected from the use of an intervention recommended in other NICE mental health guidelines for the disorder or problem that was the target of the interventions. When making this judgement the GC drew on their knowledge of and considered relevant NICE guidance.

Substance misuse – The GC were aware that some of the interventions reviewed showed some evidence of benefit (for example reduced drug misuse). These interventions included cognitive behavioural therapy, psychoeducation, pharmacological interventions such as naltrexone and the combination of psychological and pharmacological interventions. Based on their experience, the GC did not consider that there were significant harms associated with the use of psychological interventions, but were concerned that pharmacological interventions may be associated with illicit drug use and, in particular, harms associated with accidental or planned overdose. They noted that contingency management is a brief intervention, which is simple to implement and has limited potential to harm.

Individuals with suicidal risk – One study on social problem-solving intervention compared to no treatment control found an improvement in mental health outcomes (depression, anxiety and decision making ability). However, the GC took the view there was no reported evidence of a direct impact on suicidal behaviour therefore decided not to make a recommendation.

Self-help for anxiety disorders – One study compared the use of self-help materials with a wait-list control group and found a small benefit on anxiety symptoms. The evidence was rated to be of very low quality. The GC noted that there was evidence to support self-help in the non-criminal justice population with anxiety disorders but did not think that there was sufficient evidence to recommend the specific intervention under review.

PTSD – The evidence on effectiveness of focused group psychological therapy (either group or individual) found no clinically important difference and no indication of harm, compared with wait-list or supportive group therapy in studies that were of moderate to very low quality. As such, the GC did not think that there was sufficient evidence to recommend the specific interventions under review.

ADHD – Two randomised studies found no clinical benefit in the effect of oral methylphenidate compared to placebo. The GC commented that the evidence was inconclusive and did not make any recommendations that would vary from existing NICE recommended interventions for ADHD. They noted that the prescription of oral methylphenidate in the criminal justice system could result, through onward sale of the drug, in the illicit use of the drug by individuals for whom it was not prescribed leading to the possibility of harm.

Antisocial personality disorder – There was 1 trial on the reduction of aggression by tiagabine treatment compared to placebo. The evidence was of very low quality. It is not licensed for use as a mood stabiliser or for impulse control in the UK and may lower the seizure threshold in people without epilepsy and therefore the GC did not recommend tiagabine for use in the criminal justice system.

Severe mental illness – One community RCT found that paliperidone palmitate injection was more effective in reduction of first-time treatment failure (defined by a range of outcome indicators) than oral antipsychotics. The GC noted the potential harms associated with the use of depot medication and the specific indications for its use in the NICE Schizophrenia Guideline (CG178). Given the range of other, possibly less costly, depot injections available and that its license was primarily for people who had been stabilised with paliperidone or risperidone, the GC decided not to make a specific recommendation for paliperidone palmitate. The evidence for psychological intervention (the Citizenship project) and IPS intervention on quality of life, mental health outcomes and substance misuse outcomes was inconclusive. The GC did not think that there was sufficient evidence to recommend the intervention.

Parent training – There was no clinical difference on mental health outcomes on the effect of the ‘parenting from inside’ intervention compared to wait-list controls. The GC did not think that there was sufficient evidence to recommend the specific interventions under review.

Anxiety and depressive symptoms - One RCT compared the effectiveness of group counselling (with or without video feedback) with treatment as usual among prisoners in minimal community unit. The GC noted that the evidence was of very limited quality to recommend a change. Music therapy can improve anxiety and depression symptoms. However, the evidence was limited to two small studies in a non-UK setting and the GC identified no comparable recommendations in NICE guidance for depressive or anxiety disorders. There was no indication of harm in these studies. Given the low quality of the evidence and the absence of evidence in other relevant NICE mental health guidelines, the GC did not think that there was sufficient evidence to recommend the specific interventions under review.
Trade-off between net health benefits and resource useExisting economic evidence on psychological interventions for people who are in contact with the criminal justice system was limited to 1 non-UK study that found that intensive outpatient group treatment (3 days a week for 10 weeks) and anintensive day treatment programme (consisting of 4 sessions a week for 4 months or a total of 64 sessions) may potentially be cost effective for the treatment of adult offenders with a substance abuse problem. There was no economic evidence on psychological interventions for the management of other mental health problems in adults in contact with the criminal justice system.

Existing economic evidence on pharmacological interventions for people who are in contact with the criminal justice system was limited to non-UK studies and were only for substance abuse treatment in prison setting. Existing evidence indicated that prison-based pharmacological treatments are associated with reduced rates of re-offending, reduced incidence of HCV, improved survival and as a result may potentially be cost effective in people with substance misuse who are in prisons. There was no evidence on pharmacological interventions for the management of other mental health problems in adults in contact with the criminal justice system.

The GC considered the economic consequences arising from the presence of mental health problems in people who are in contact with the criminal justice system that is associated with the consumption of extra healthcare resources. The GC also considered the impact of mental health problems on mortality (increased risk of suicide) and HRQoL and concluded that the provision of effective psychological and pharmacological interventions for the management of mental health problems is likely to improve survival and HRQoL in this population. If untreated, the symptoms are likely to get worse and require the management of mental health problems in more resource-intensive settings, such as secondary care or require expensive crisis care. Also, once released back in the community, service users with untreated mental health problems are likely to have repeat interface with the criminal justice system, because their problems are likely to be getting even worse. The GC also considered the impact of potential self-harm and suicide on the HRQoL of family members. All of the above are likely to result in a significant increase in healthcare, social care and criminal justice sector costs.

The GC expressed the opinion that, for safety reasons, people with mental health problems in criminal justice settings receiving pharmacological treatments may benefit from closer monitoring. The GC concluded that additional monitoring would ensure that service users received adequate and effective treatment. The GC acknowledged that provision of pharmacological interventions to people who are in contact with the criminal justice system may be more resource-intensive compared with provision of pharmacological interventions in the general population and this may have implications for the cost effectiveness of such interventions, but considered that additional monitoring, support and further adaptations in the pharmacological treatment of people with mental health problems who are in contact with criminal justice system are essential in order to achieve a positive outcome.

There was no economic evidence on contingency management for people with substance misuse. The GC acknowledged that provision of such programmes to people who are in contact with the criminal justice system may require additional resources (e.g. costs associated with the voucher or prize incentives, urine testing). The GC also considered the economic consequences arising from the presence of mental health problems in people who are in contact with the criminal justice system that is associated with the consumption of extra healthcare resources. The GC expressed the view that the additional costs of the interventions are very likely to be justifiable by the potential improvements in mental health outcomes and potential reduction in reoffending (the link between illicit drug use and crime is well established) as was demonstrated in the NICE Guideline on psychosocial interventions in Drug Misuse.

The GC also considered issues relating to equality and judged that psychological (including contingency management) and pharmacological interventions for the management of mental health problems that have been shown to be cost effective in general population should also be offered to people with mental health problems who are in contact with the criminal justice system, following necessary adaptations and additional monitoring.
Quality of evidenceMost of the evidence reviewed was of very low to low quality. There were a large number of small studies, for example in substance misuse that used a broad range of different interventions and comparators which limited the extent to which data could be pooled. Some of the better quality evidence reviewed was for contingency management. The GC noted that just because the reviewed evidence showed no effect, this does not mean conclusively that an intervention has no benefit, it may reflect the limited nature of the current evidence for the treatment of these disorders in the criminal justice system.
Other considerationsThe GC were aware of the need for effective interventions for individuals in contact with the criminal justice system that are in line with existing NICE guidance for the general population. The GC identified nothing in the reviews undertaken for this guideline which would suggest that current available treatment would not be of benefit to those in contact with the criminal justice system. In addition, they identified no significant harms, save for the possible diversion of prescribed drugs (e.g. methylphenidate) which would be of significant concern.

With this in mind, the GC developed through informal consensus a set of principles that would guide the use of NICE guidance on mental health interventions in the criminal justice system and identifying, where necessary, where specific modifications to the intervention or the manner in which it is delivered were needed. The GC were of the view that when using NICE mental health guidelines in the criminal justice system the degree of learning disabilities or acquired cognitive impairment, communication difficulties, coexisting mental health problems, limits on the limitations on prescribing and administering medicine (e.g. in-possession medicine), the development of trust in an environment where health and care staff may be held in suspicion, cultural and ethnic differences in beliefs about mental health problems, differences in presentation of mental health problems and the setting in which the assessment or treatment takes place, should be borne in mind. Other principles concerned the modification of the delivery of psychological interventions and the need to ensure continuity of psychological care across the pathway. For pharmacological interventions the GC recognised the need to modify drug prescribing to take into account in-possession medication, the administration times for medication, the availability of medicines in the first 48 hours of transfer to prison and the availability of medicines after release from prison. They also wanted to draw attention to the importance of proper prescribing for the management of attention deficit hyperactivity disorder, sleep problems and chronic pain management.

The GC made a number of recommendations for the delivery of psychological and pharmacological interventions in the criminal justice system. However they were aware of the difficulties many of the individuals in the criminal justice system have in engaging and so making use of interventions available. Emerging evidence from other areas of mental health care, for example personality disorders suggest that structured clinical management may be effective in improving uptake and outcomes from services. To date this emerging evidence has been limited to the delivery of structured case management in health care environment. The GC decided to make a research recommendation for the testing of structured clinical management in probation service providers.

6.5.1. Research recommendation (see also Appendix G)

5.

What is the effectiveness of structured clinical (case) management in improving mental health outcomes using interventions within probation service providers? (Key Research Recommendation)

Many people in contact with the community-based criminal justice services, have significant mental health problems, in particular, personality problems and interpersonal difficulties. Evidence from studies of people with such problems in general mental health services suggests that structured organisation and delivery of mental health interventions (structured clinical management) may be of benefit in improving mental health outcomes. A programme of research is needed which would first refine and develop structured clinical management for use in the community rehabilitation companies (CRCs) and the National Probation Service (NPS) and then test this in large scale randomised control trials in both CRCs and the NPS. The comparison should be against standard CRC and NPS care. The trial should consider both clinical outcomes and cost-effectiveness.

Important outcomes could include:

  • Mental health outcomes
  • Offending and re-offending rates
  • Service utilisation
  • Cost-effectiveness
  • Broader measures of social functioning

6.6. Review question: For adults with a paraphilic disorder who are in contact with the criminal justice system, what are the benefits and harms of psychological, social or pharmacological interventions aimed at reducing or preventing the expression of paraphilic behaviour, or preventing or reducing sexual offending or reoffending?

The review protocol summary, including the review question and the eligibility criteria used for this section of the guideline, can be found in Table 118. A complete list of review questions and review protocols can be found in Appendix F; further information about the search strategy can be found in Appendix H.

Table 118. Clinical review protocol summary for the review on interventions aimed at reducing or preventing the expression of paraphilic behaviour, sexual offending or reoffending in adults with a paraphilic disorder who are in contact with the criminal justice system.

Table 118

Clinical review protocol summary for the review on interventions aimed at reducing or preventing the expression of paraphilic behaviour, sexual offending or reoffending in adults with a paraphilic disorder who are in contact with the criminal justice (more...)

6.6.1. Clinical evidence

6.6.1.1. Pharmacological interventions

Three RCTs (N = 84) met the eligibility criteria for this review. These trials were identified in a systematic review (Khan et al., 2015) of seven RCTs, four of which were excluded from this review because they involved psychiatric inpatients or were cross-over trials where the first phase data could not be extracted.

The included trials involved medroxyprogesterone acetate (MPA) a synthetic progesterone proposed to supress sexual desire by countering the libidinal effects of testosterone. Hucker et al. (1988) compared MPA with placebo for paedophilia in the outpatient setting. Langevin et al. (1979) and McConaghy et al. (1988) examined the addition of MPA to outpatient psychological interventions for exhibitionism or varied paraphilic disorders respectively.

An overview of the trials included in the meta-analysis can be found in

Table 119. Further information about both included and excluded studies can be found in Appendix L.

Summary of findings can be found in N= total number of participants

MPA = Medroxyprogesterone acetate

Psych= Psychosocial

mg/day = milligrams per day

CJS = Criminal justice system

1 Number randomised

Table 120 and 1 Downgraded for inconsistency

2. Confidence interval of the effect estimate includes appreciable benefit, harm and no effect

3. High risk of selection and performance bias

4. High risk of selection and performance bias.

Table 121. The full GRADE evidence profiles and associated forest plots can be found in Appendices N and O, respectively.

Table 119. Study information table for trials included in the meta-analysis of pharmacological interventions for paraphilia.

Table 119

Study information table for trials included in the meta-analysis of pharmacological interventions for paraphilia.

Table 120. Summary of findings table for medroxyprogesterone + psychological intervention compared to psychological intervention only for paraphilic disorders.

Table 120

Summary of findings table for medroxyprogesterone + psychological intervention compared to psychological intervention only for paraphilic disorders.

Table 121. Summary of findings table for medroxyprogesterone compared to placebo for paraphilic disorders.

Table 121

Summary of findings table for medroxyprogesterone compared to placebo for paraphilic disorders.

6.6.1.2. Psychoeducational interventions

Three RCTs (N=779) and 23 non-randomised controlled trials (N=12317) met the eligibility criteria for this review. The randomised trials were identified in a systematic review (Dennis et al., 2012): Anderson Varney (1991) and Hopkins (1991) compared CBT based psychoeducational interventions to treatment as usual or waiting list control. Marques et al. (1994a) examined the California Sex Offender Treatment and Evaluation Project. No trials published after this systematic review were found.

The non-randomised controlled trials (Abracen et al., 2011; Aytes et al., 2001; Craissati & McClurg, 1997; Craissati et al., 2009; Di Fazio et al., 2001; Duwe & Goldman, 2009; Friendship et al., 2003; Hanson et al., 2004; Looman et al., 2000; Lowden et al., 2003; Marshall et al., 2008; McGrath et al., 2003; McGrath et al., 1998; McGuire, 2000; O’Reilly et al., 2010; Olver et al., 2013a; Redondo Illescas & Garrido Genoves, 2008; Ruddijs & Timmerman, 2000; Song & Lieb, 1995; Stalans et al., 2001; Turner et al., 2000) involved primarily group CBT based psychoeducation (including SOTP). Content of the psychoeducation included: offence disclosure, accepting responsibility, cognitive distortions/cognitive restructuring, victim empathy, offending cycle, individual risk factors and recognition cues, relapse prevention and social skills. Methods included group discussion, exposure to video or audio accounts presented by victims, positive modelling, role-play, skills practice and decision matrices. The control groups received either no treatment, treatment as usual (which was not specified) or were waitlist controls.

An overview of the trials included can be found in

Table 122. Further information about both included and excluded studies can be found in Appendix L.

Summary of findings can be found in CBT= cognitive behavioural therapy

SOTP= sex offender treatment programme

RCT= randomised controlled trial

Table 123 and 1 Anderson-Varney 1991 - unclear risk of selection bias; no blinding; low risk of attrition bias; low risk of selective outcome bias; low risk of other bias

2 The MID calculated from SD of control was +/-5.41.

3 The MID calculated from SD of control was +/-6.01.

4 Hopkins 1991 - Unclear selection bias; No blinding; low risk of attrition bias; low risk of selective outcome bias; low risk of other bias.

5 Hopkins 1991 - Participants involved roughly equal numbers of incarcerated paedophile and rapists

6 Indirectness – inpatient setting

7 Imprecision – the CI for the effect spans no effect and both MID thresholds

Table 124. The full GRADE evidence profiles and associated forest plots can be found in Appendices N and O, respectively.

Significant heterogeneity was noted in some of the outcomes and subgroup analysis was done according to country (which reduced heterogeneity) and reported in the summary of findings tables. No other sources of heterogeneity were identified: the non-randomized controlled trials were typically not adjusted for confounders.

Table 122. Study information table for trials included in the analysis of psychoeducational interventions for paraphilia.

Table 122

Study information table for trials included in the analysis of psychoeducational interventions for paraphilia.

Table 123. Summary of findings table (RCTs) for psychoeducational interventions, principally CBT-informed psychoeducation (including SOTP) versus treatment as usual, no treatment or waitlist control for paraphilic disorders.

Table 123

Summary of findings table (RCTs) for psychoeducational interventions, principally CBT-informed psychoeducation (including SOTP) versus treatment as usual, no treatment or waitlist control for paraphilic disorders.

Table 124. Summary of findings table (observational studies) for psychoeducational interventions, principally CBT-informed psychoeducation (including SOTP) versus treatment as usual, no treatment or waitlist control for paraphilic disorders.

Table 124

Summary of findings table (observational studies) for psychoeducational interventions, principally CBT-informed psychoeducation (including SOTP) versus treatment as usual, no treatment or waitlist control for paraphilic disorders.

6.6.1.3. Good Lives Model (GLM) versus Relapse Prevention (RP)

Two non-randomised controlled studies (N=1278) met the eligibility criteria for this review. Barnett et al. (2014) and Harkins et al. (2012) compared the Good Lives Model or the revised Better Lives Model with standard relapse prevention in UK sexual offenders against children.

An overview of the trials included can be found in

Table 125. Further information about both included and excluded studies can be found in Appendix L.

A summary of findings can be found in Table 126. The full GRADE evidence profiles and associated forest plots can be found in Appendices N and O, respectively.

Table 125. Study information table for trials included in the analysis of Good Lives Model versus Relapse Prevention for paraphilia.

Table 125

Study information table for trials included in the analysis of Good Lives Model versus Relapse Prevention for paraphilia.

Table 126. Summary of findings table for Good Lives Model (GLM) versus Relapse Prevention (RP) for paraphilic disorders.

Table 126

Summary of findings table for Good Lives Model (GLM) versus Relapse Prevention (RP) for paraphilic disorders.

6.6.1.4. Reintegration programmes

One RCT (Duwe, 2013)(N=62) and three non-randomised controlled trials (Bates et al., 2014; Wilson et al., 2009; Wilson et al., 2007b) (N=350) met the eligibility criteria for this review. All of the studies involved the Circles of Support and Accountability (COSA) intervention. The COSA inner circle consists of the core member (the sex offender) and up to six volunteers from the community. The COSA outer circle consists of, supervision agents, law enforcement personnel and treatment professionals. Volunteers are recruited and trained in preparation for their role, with topics covered such as typology, manipulation, personal boundaries and managing risk. The goal for each circle is to provide the core member with support during their reintegration into the community.

An overview of the trials included can be found in

Table 127. Further information about both included and excluded studies can be found in Appendix L.

Summary of findings can be found in Table 128 and Table 129. The full GRADE evidence profiles and associated forest plots can be found in Appendices N and O, respectively.

Table 127. Study information table for trials included in the analysis of reintegration programmes versus treatment as usual for paraphilia.

Table 127

Study information table for trials included in the analysis of reintegration programmes versus treatment as usual for paraphilia.

Table 128. Summary of findings table (RCTs) for reintegration programmes versus treatment as usual for paraphilic disorders.

Table 128

Summary of findings table (RCTs) for reintegration programmes versus treatment as usual for paraphilic disorders.

Table 129. Summary of findings table (observational studies) for reintegration programmes versus treatment as usual for paraphilic disorders.

Table 129

Summary of findings table (observational studies) for reintegration programmes versus treatment as usual for paraphilic disorders.

6.6.1.5. Therapeutic communities

One non-randomised controlled trial (N=1217) met the eligibility criteria for this review. Lowden et al. (2003) involved the Sex Offender Treatment and Monitoring Programme (SOTMP) phase 1 and 2, a modified sex offender therapeutic community housing inmates together in a therapeutic milieu where individuals work and live with others who are working on similar treatment issues.

An overview of the trial can be found in Table 130. Further information about both included and excluded studies can be found in Appendix L.

Summary of findings can be found in Table 131. The full GRADE evidence profiles and associated forest plots can be found in Appendices N and O, respectively.

Table 130. Study information table for trials included in the analysis of therapeutic communities versus no treatment for paraphilia.

Table 130

Study information table for trials included in the analysis of therapeutic communities versus no treatment for paraphilia.

Table 131. Summary of findings table for Therapeutic communities versus no treatment for paraphilic disorders.

Table 131

Summary of findings table for Therapeutic communities versus no treatment for paraphilic disorders.

6.6.1.6. Cognitive behavioural therapy

One non-randomised controlled trial (N=61) met the eligibility criteria for this review. Marshall et al. (1991) involved a treatment programme that conceptualized exhibitionism in cognitive and social terms, rather than simply sexual motivation. Treatment was aimed at teaching skills to deal with all sources of stress and intervention content included: assertiveness training; stress management; cognitive restructuring; training in relationship skills.

An overview of the trial can be found in Table 132. Further information about both included and excluded studies can be found in Appendix L.

Summary findings can be found in Table 133. The full GRADE evidence profiles and associated forest plots can be found in Appendices N and O, respectively.

Table 132. Study information table for trials included in the analysis of cognitive behavioural therapy versus treatment as usual for paraphilia.

Table 132

Study information table for trials included in the analysis of cognitive behavioural therapy versus treatment as usual for paraphilia.

Table 133. Summary of findings table for cognitive behavioural therapy (CBT) versus treatment as usual for paraphilic disorders.

Table 133

Summary of findings table for cognitive behavioural therapy (CBT) versus treatment as usual for paraphilic disorders.

6.6.1.7. Behavioural therapy

Two randomised controlled trials (McConaghy et al., 1985; McConaghy et al., 1988) and two non-randomised controlled trials (Marshall & Barbaree, 1988b; Marshall et al., 1991) (N=187) met the eligibility criteria for this review.

McConaghy et al. (1985) compared imaginal desensitization to covert sensitization for varied paraphilic disorders. McConaghy et al. (1988) examined the addition of imaginal desensitization to MPA for varied paraphilic disorders. Marshall & Barbaree (1988b) and Marshall et al., (1991) compared behavioural treatment programs to treatment as usual in paedophiles and exhibitionists respectively

An overview of the trials can be found in Table 134. Further information about both included and excluded studies can be found in Appendix L.

Summary of findings can be found in N= total number of participants; NR=Not reported; MPA = medroxyprogesterone

1 Number randomised

Table 135, 1 Marshall 1988a/b/1991 - Non-RCT with 4 and 9-year follow-up; No baseline risk differences; No blinding; unclear attrition risk of bias; low risk of selective outcome bias; low risk of other bias

2 The 95% CI considered for imprecision was 0.80 to 1.25.

Table 136 and 1 McConaghy 1988 - unclear risk of selection bias, no blinding, low risk of attrition bias, high risk of selective outcome bias, low risk of other bias.

2 Unclear what percentage are currently in contact with the criminal justice system

3 The 95% CI considered for imprecision was 0.80 to 1.25.

Table 137. The full GRADE evidence profiles and associated forest plots can be found in Appendices N and O, respectively.

Table 134. Study information table for trials included in the analysis of behavioural therapy for paraphilia.

Table 134

Study information table for trials included in the analysis of behavioural therapy for paraphilia.

Table 135. Summary of findings table for behavioural therapies versus treatment as usual for paraphilic disorders.

Table 135

Summary of findings table for behavioural therapies versus treatment as usual for paraphilic disorders.

Table 136. Summary of findings table behavioural therapy plus medroxyprogesterone versus other medroxyprogesterone alone.

Table 136

Summary of findings table behavioural therapy plus medroxyprogesterone versus other medroxyprogesterone alone.

Table 137. Summary of findings table for imaginal desensitization versus covert sensitization for paraphilic disorders.

Table 137

Summary of findings table for imaginal desensitization versus covert sensitization for paraphilic disorders.

6.6.1.8. Aversive conditioning training and milieu therapy

One non-randomised controlled trial (N=197) met the eligibility criteria for this review. Hanson et al. (1993) examined a specialised treatment programme provided in a separate minimum security setting. The programme aimed to increase the social competence of offenders through individual and group counselling and by creating a therapeutic milieu that encouraged the men to recognise and correct social and sexual adjustment problems. The offenders also received aversive conditioning training, involving pairing shocks to stimulus sets tailored for each participant on the basis of their offence history.

An overview of the trial can be found in Table 138. Further information about both included and excluded studies can be found in Appendix L.

Summary of findings can be found in N= total number of participants; NR=Not reported

1 Number randomised

Table 139. The full GRADE evidence profiles and associated forest plots can be found in Appendices N and O, respectively.

Table 138. Study information table for trials included in the analysis of aversive conditioning training and milieu therapy for paraphilia.

Table 138

Study information table for trials included in the analysis of aversive conditioning training and milieu therapy for paraphilia.

Table 139. Summary of findings table for aversive conditioning and milieu therapy versus treatment as usual for paraphilic disorders.

Table 139

Summary of findings table for aversive conditioning and milieu therapy versus treatment as usual for paraphilic disorders.

6.6.1.9. Individual and Group Psychotherapy

Two non-randomised controlled trials (Craissati 2009, Peters 1968; N=440) met the eligibility criteria for this review. Peters et al. (1968) involved a group psychotherapy programme for sex offenders. Craissati et al. (2009) involved individual supportive psychotherapy for sex offenders deemed inappropriate for more structured offence-focused treatment due to disruptive or antagonistic behaviour or denial of the offence

An overview of the trials can be found in Table 140. Further information about both included and excluded studies can be found in Appendix L.

Summary of findings can be found in N= total number of participants; NR=Not reported

1 Number randomised

Table 141. The full GRADE evidence profiles and associated forest plots can be found in Appendices N and O, respectively.

Table 140. Study information table for trials included in the analysis of psychotherapy versus no treatment or treatment as usual for paraphilia.

Table 140

Study information table for trials included in the analysis of psychotherapy versus no treatment or treatment as usual for paraphilia.

Table 141. Summary of findings table for psychotherapy versus no treatment or treatment as usual for paraphilic disorders.

Table 141

Summary of findings table for psychotherapy versus no treatment or treatment as usual for paraphilic disorders.

6.6.1.10. Polygraph testing

One controlled non randomised study (N=208) met the eligibility criteria for this review. McGrath et al. (2007) examined the effectiveness of periodic polygraph compliance exams as a condition of probation or parole in a group of primarily sex offenders against children.

An overview of the trial can be found in Table 142. Further information about both included and excluded studies can be found in Appendix L.

Summary of findings can be found in N= total number of participants; NR=Not reported

1 Number randomised

Table 143. The full GRADE evidence profiles and associated forest plots can be found in Appendices N and O, respectively.

Table 142. Study information table for trials included in the analysis of polygraph testing versus treatment as usual for paraphilia.

Table 142

Study information table for trials included in the analysis of polygraph testing versus treatment as usual for paraphilia.

Table 143. Summary of findings table for polygraph testing versus treatment as usual for paraphilic disorders.

Table 143

Summary of findings table for polygraph testing versus treatment as usual for paraphilic disorders.

6.6.2. Economic evidence

The systematic search of the literature identified 1 Australian study in two publications that assessed the cost-benefit of psychological therapy for adults with a paraphilic disorder who are in contact with the criminal justice system Donato 2001 (Donato & Shanahan, 2001); Shanahan 2001 (Shanahan & Donato, 2001).

No studies assessing the cost effectiveness of pharmacological interventions for adults with a paraphilic disorder who are in contact with the criminal justice system were identified by the systematic search of the economic literature undertaken for this guideline.

Details on the methods used for the systematic review of the economic literature are described in Chapter 3; full references and evidence tables for all economic evaluations included in the systematic literature review are provided in Appendix S. Completed methodology checklists of the studies are provided in Appendix R. Economic evidence profiles of studies considered during guideline development (that is, studies that fully or partly met the applicability and quality criteria) are presented in Appendix T.

Donato & Shanahan (2001) conducted a cost-benefit analysis of intensive prison-based paedophile treatment (CBT) in Australia. This was a modelling study with clinical effectiveness data based on published sources and authors’ assumptions. The time horizon of the economic analysis was lifetime and its perspective was public sector (healthcare, social care and out of pocket expenses). Cost elements comprised CBT provision, the judiciary (court), police, family services (counselling, mediation, child contact services, domestic violence prevention programmes), child-focused health services, medicines, medical services (psychiatrists, general practitioners), out-of-pocket expenses by victims and their families, incarceration and other victim and offender related expenses. Cost data were obtained from various international, federal and state level sources and authors’ assumptions. The analysis utilised the net benefit (NB) framework. The NB was defined as the sum of tangible benefits (resource savings) and intangible benefits (value of health consequences such as avoiding pain and suffering) less the programme provision costs. Intangible benefits were valued using both revealed preferences and contingent valuation methods. When using revealed preferences approach intangible benefits were approximated using a US study that reported the amounts compensated in child sex abuse cases. When using the contingent valuation method intangible benefits were approximated by linking road traffic injuries and associated costs with injuries associated with sexual abuse.

The analysis demonstrated that the total programme provision cost was $10,000 per treated prisoner, the tangible benefits of preventing re-offense were approximately $157,290 and the intangible benefits of preventing re-offense varied from $0 to $198,900 depending on the monetary valuation placed upon intangible benefits (in 1998 AUS dollars). Based on the above the economic benefits associated with intensive prison-based CBT ranged from an expected net loss of $6,850 to an expected NB of $39,870 per treated prisoner (depending on the monetary valuation placed upon intangible benefits and the efficacy of the treatment programme). For example, when intangibles were valued at zero and prison-based CBT was assumed to reduce recidivism by 2%, the intervention resulted in a net loss of $6,850 per treated prisoner. However, when intangibles were valued at ten times the value of tangible benefits and intervention was assumed to reduce recidivism rate by 14%, the economic benefits were expected to reach $39,870 per treated prisoner. The deterministic sensitivity analysis indicated that if there were two victims per re-offender the economic benefits of a treatment programme would range from an expected net loss of $6,850 to an expected net benefit of $76,710 per treated prisoner (again depending on the monetary valuation placed upon intangible benefits and the efficacy of the treatment programme). Based on these results, the authors concluded that ‘based on a reasonable set of parameter estimates, prison-based CBT for paedophiles is likely to be of net benefit to society’ (Donato & Shanahan, 2001).

This study is only partially applicable to the NICE decision-making context. It was conducted in Australia and the measure of outcome was not expressed in QALYs. The study was judged by the GC to have potentially serious limitations. Clinical effectiveness (recidivism rate) was based on authors’ assumptions. The valuation of intangible costs was approximated using compensation rates for road traffic accident victims when using revealed preferences approach the values. Resource use and unit cost data were based on a mixture of national and local sources and as necessary were supplemented with information from published studies.

6.6.3. Clinical evidence statements

6.6.3.1. Pharmacological interventions

Very low quality evidence from two randomised controlled trials (N=66) indicated uncertainty about the benefit of adding MPA to psychosocial interventions for paraphilia in terms of anomalous desires or behaviour.

Low quality evidence from one randomised controlled trial (N = 32) indicated that adding MPA to a psychosocial intervention for paraphilia increased the risk of study dropout by a clinically important amount compared to the psychological intervention alone.

Very low quality evidence from one randomised controlled trial (N=20) indicated uncertainty about whether MPA alone was more effective than imaginal desensitization alone in terms of anomalous desires or behaviour.

6.6.3.2. Psychoeducational interventions

Moderate quality evidence from one randomised controlled trial (N=60) indicated that a psychoeducational CBT intervention reduced cognitive distortions by a clinically important amount when compared to no treatment. This trial provided low quality evidence of uncertainty about the effects of psychoeducation on acceptance of accountability, sexual anxiety and anxiety.

The only evidence about reconviction from randomised studies was from a single trial in the inpatient setting (N =480), which provided low quality evidence of uncertainty about the benefit of psychoeducation in terms of sexual or violent reconviction rates.

Very low quality evidence from nine non-randomised controlled trials (N=2796) indicated that psychoeducational interventions led to a clinically important reduction in reconviction rates when compared to treatment as usual, no treatment or waitlist control. This was also the case when restricting the analysis to UK studies (1 study; N=338).

There was very low quality evidence from 11 non-randomised controlled trials (N=5261) that psychoeducational interventions were associated with a clinically important reduction in reconviction rates for sexual offenses when compared to treatment as usual, no treatment or waitlist control. There was very low quality evidence of uncertainty about the effect of psychoeducation on reconviction for sexual offenses when restricting the analysis to UK studies (three studies; N=2885).

There was very low quality evidence from 6 non-randomised controlled trials (N=2181) that psychoeducational interventions were associated with a clinically important reduction in reconviction rates for violent offenses when compared to treatment as usual, no treatment or waitlist control. There was very low quality evidence of uncertainty about the effect of psychoeducation on reconviction for violent offenses when restricting the analysis to UK studies (1 study; N=240).

There was very low quality evidence from 6 non-randomised controlled trials (N=2181) of uncertainty about the effect of psychoeducational interventions on revocation rates when compared to treatment as usual, no treatment or waitlist control. There was very low quality evidence of a clinically important reduction in revocation rates with psychoeducation when restricting the analysis to UK studies (1 study; N=240).

6.6.3.3. Good Lives Model (GLM) versus Relapse Prevention (RP)

Very low quality evidence from one non-randomised controlled trial (N=501) suggested that the Good Lives Model reduced cognitive distortions and emotional congruence with children by a clinically important amount when compared with relapse prevention.

Very low quality evidence from one non-randomised controlled trial (N=501) suggested no clinically important difference in the effectiveness of the Good Lives Model and relapse prevention in terms of victim empathy distortions.

Very low quality evidence from one non-randomised controlled trial (N=2698) suggested uncertainty about the relative treatment dropout rates associated with the Good Lives Model and relapse prevention.

Low quality evidence from one RCT (N=587) indicated no clinically important difference in the effectiveness of Good Lives Model and relapse prevention for reducing pro-offending attitudes.

There was no evidence about the relative effectiveness of the Good Lives Model and relapse prevention in terms of offending or reoffending.

6.6.3.4. Reintegration programmes

One randomised trial (N = 62) provided very low quality evidence that a support group, Circles of Support and Accountability, reduced rates of re-arrest at two years of follow-up by a clinically important amount compared to treatment as usual. From this trial there was very low quality evidence of uncertainty about the relative effectiveness of the support group compared to treatment as usual in terms of: sex offence re-arrest, reconviction, resentence and re-incarceration at two years follow up.

Very low quality evidence from three non-randomised controlled trials (N=350) indicated reintegration programmes were associated with clinically important reductions in reconviction rates (including for sexual offenses) when compared to treatment as usual. Restricting the analysis to UK only studies there was uncertainty whether reintegration programmes were more effective than treatment as usual.

6.6.3.5. Therapeutic communities

Very low quality evidence from one non-randomised controlled trials (N=1217) indicated therapeutic communities reduced rates of re-arrest, incarceration and revocation by a clinically important amount compared with no treatment. There was however uncertainty about the effectiveness of the therapeutic community intervention in terms of re-arrest or incarceration when looking at specific sexual or violent offenses.

6.6.3.6. Cognitive behavioural therapy

Very low quality evidence from one non-randomised controlled trial (N=38) indicated uncertainty about whether CBT reduces the rate of sexual reconviction when compared with treatment as usual.

6.6.3.7. Behavioural therapy

Very low quality evidence from a small non-randomised controlled trial (N=44) suggested a behavioural treatment programme had a clinically important effect on sexual reconviction rates at 4 years of follow up in sex offenders against children but there was uncertainty about its effectiveness for sexual reconviction rates at 9 years in exhibitionists.

Very low quality evidence from a randomised trial (N=20) indicated uncertainty about the relative effectiveness of imaginal desensitization plus MPA versus MPA alone in terms of anomalous desires and behaviours.

Very low quality evidence from a randomised trial (N=20) indicates uncertainty about the relative effectiveness of imaginal desensitization versus covert sensitisation alone in terms of anomalous desires and behaviours.

6.6.3.8. Aversive conditioning training and milieu therapy

Very low quality evidence from one non-randomised controlled trial (N=197) indicated uncertainty about whether aversive conditioning training and milieu therapy is more or less effective than treatment as usual in terms of sexual or violent reconvictions.

6.6.3.9. Individual and Group Psychotherapy

Low quality evidence from one non-randomised controlled trial (N=167) indicated a clinically important reduction in re-arrest rates following psychotherapy for paraphilic disorders when compared to treatment as usual.

Low quality evidence from two non-randomised controlled trials (N=335) indicated uncertainty about the effectiveness of psychotherapy for paraphilic disorders when compared to no treatment or treatment as usual in terms of sex-offence re-arrest or reconviction, violent reconviction and breaches of the sex offender register.

6.6.3.10. Polygraph testing

Very low quality evidence from a non-randomised controlled trial (N=208) indicated uncertainty about the effectiveness of periodic polygraph compliance exams when compared to treatment as usual in terms of sexual reconviction, incarceration or violation of supervision conditions. Violent reconviction, however, was reduced by a clinically important amount in the polygraph testing group.

6.6.4. Economic evidence statements

No evidence on the cost effectiveness of pharmacological interventions for adults with a paraphilic disorder who are in contact with the criminal justice system is available.

There was evidence from 1 Australian study on the cost-benefit of psychosocial intervention for adults with a paraphilic disorder who are in contact with the criminal justice system. The analysis was based on modelling suggesting that prison-based, cognitive behavioural therapy treatment programme for paedophiles may be of net benefit to society. The economic benefits associated with intensive prison-based CBT ranged from an expected net loss of $6,850 to an expected NB of $39,870 per treated prisoner (depending on the monetary valuation placed upon intangible benefits and the efficacy of the treatment programme). This evidence is partially applicable to the NICE decision-making context since it was Australian study and is characterised by potentially serious limitations, including clinical effectiveness (recidivism rate), being based on authors’ assumptions, the valuation of intangible costs (pain and suffering) being undertaken using both contingent valuation and revealed preferences methods. However, when using revealed preferences approach the values were approximated using compensation rates for road traffic accident victims. Resource use and unit cost data were based on a mixture of national and local sources supplemented with information from the published studies. The GC could not draw any conclusions based on this evidence.

6.7. Recommendations and link to evidence

Recommendations
43.

Consider psychological interventions for paraphilias only when delivered as part of a research programme.

Relative values of different outcomesThe GC considered offending and reoffending (for example paraphilic activity), to be the critical outcomes for this question. Some studies reported cognitive distortions (measure of attitudes or beliefs to paraphilic activity). But the GC did not consider this to be a good surrogate offending behaviour. There was no evidence for service utilisation, adaptive functioning or rates of self-injury.
Trade-off between clinical benefits and harmsPsychological, including psychoeducational interventions and pharmacological interventions for paraphilia’s aim to reduce the rate of sexual offending. This has potential benefits for future potential victims of such offences, their families and communities. These benefits may be substantial and long-lasting given that such offences, in particular against children, may be associated with lifelong harm. Interventions also aim to reduce the distress experienced by the offender and improve their mental health and attitudes toward sexual offending.

A large number of psychological interventions were reviewed, although the majority were not randomised. The clearest indication of a benefit came from the studies of psychoeducational interventions, which were of low quality. The estimate of the outcomes, typically reduction in offending, was uncertain. Evidence from a range of observational studies or small randomised trials for a range of other psychological interventions including relapse prevention, reintegration programmes, therapeutic communities, cognitive and behavioural therapies, aversion therapy or individual and group psychotherapy produced low quality evidence which the GC did not think could support any recommendation. Polygraph testing in a small single low quality study suggested some benefit on violent reconviction. However, the GC did not think that they could support a recommendation for such testing.

Very low quality evidence from three randomised controlled trials did not show clear benefit for medroxyprogesterone acetate alone or in combination with a psychological interventions. Medroxyprogesterone acetate was associated with high attrition from treatment. The GC did not think that they could make a treatment recommendation for its use.

The primary harms are associated with the use of anti-adrenergic drugs. These are associated with significant side effects, including breast development in men. These side effects are also associated with a high drop-out and poor compliance with treatment regimens. In addition, many programmes, including many psychological interventions, are delivered in custodial environments where attitude change may be a proxy indicator of benefit. But in the absence of any opportunity to asses a reduction in offending behaviour this may lead to under-estimation of the risk of re-offending after completion of treatment.
Trade-off between net health benefits and resource useThe costs of treatment are limited as they consist of time limited psychological interventions which can be delivered in community or residential settings including prisons. However, the majority of psychological or pharmacological interventions (which require the prescription and monitoring of patent drugs) do not need to be delivered in residential settings. Long-term monitoring of pharmacological interventions or follow up of psychological interventions will often take place in a context where long-term monitoring of the risk of reoffending is undertaken. Effective treatment will reduce the use of resources associated with the care of the individual with paraphilia and contribute to a use of health care resource by individuals who would have become victims of sexual offences if the problem was not successfully treated. One Australian cost-effectiveness study of limited applicability suggested that psychological interventions in a prison setting may be cost effective. The GC thought that this study had significant limitations including the parameters included in the economic model, the populations included in the study and the assumptions made by the authors of the study about the effectiveness of the interventions.
Quality of evidenceThe quality of the evidence from a small number of RCTs and a larger number of non-randomised controlled trials ranged from moderate to very low. The randomised trials typically had small sample sizes leading to wide confidence intervals for effect estimates. Although they generally showed evidence of benefit on reoffending and attitudes across a range of interventions (the majority of which consisted of specially developed CBT based psycho-educational interventions), there was uncertainty about the harms and benefits of the interventions. Only one of the randomised trials used adequate blinding. Many of the studies which included sex offenders did not report the proportion and type of paraphilic disorders, the particular focus of this review. The guideline committee were concerned that populations in these studies might not be applicable to those with paraphilic disorders seen in the UK criminal justice system. The UK system has a high proportion of paedophiles and the proportion of those in non-UK studies was less than in the UK. For this reason they paid close attention to the sub-group analysis of UK studies. The evidence as a whole suggested that psychological interventions, including psychoeducational interventions, may be effective in reducing re-conviction rates. However, the evidence was not as clear as non-UK based studies to support their effectiveness in reducing re-conviction for sexual offences in the UK and in particular in the populations likely to managed in the UK criminal justice system.
Other considerationsThe National Offender Management Service (NOMS) Psychology and Interventions Teams provide an accredited Sex Offender Treatment Programme for those in custody in England and Wales. The GC thought that because this programme is currently the standard intervention used across the criminal justice system, is well delivered and has good outcome monitoring in place, evidence about its effectiveness was essential to inform any recommendations in this guideline about treatment of paraphilic disorders within the UK criminal justice system.

Although an expert witness from NOMS provided testimony on co-commissioning mental health services for offenders, NOMS did not agree to a GC request to release relevant reports or data from the outcome of their Sex Offender Treatment Programme. Given the absence of evidence from the NOMS programmes and the uncertainty about the evidence reviewed, in particular the UK evidence, the GC decided to make no treatment recommendations about interventions for people with paraphilic disorders.

Instead, they recommended that psychological interventions for paraphilias only be delivered as part of a research programme. Given the high drop-out rate and poor compliance identified in the review of pharmacological interventions and lack of direct evidence on sexual offending the GC did not make a recommendation about drug treatments. Given the importance of this topic the GC also made a further research recommendation to determine if either pharmacological or psychological interventions are effective in reducing reoffending in paraphilic disorders. This should address the use of these interventions in a range of settings in the UK criminal justice system.

6.7.1. Research recommendations (see also Appendix G)

6.

What is the clinical effectiveness, cost effectiveness and safety of specific psychological and pharmacological interventions both in and out of prison among people with paraphilic disorders? (Key Research Recommendation)

The limited evidence for pharmacological interventions (for example, medroxyprogesterone acetate) provides no clear evidence of benefit in people with paraphilias. A randomised trial with an adequate sample size is needed to examine the effectiveness of medroxyprogesterone acetate in these populations.

There is insufficient evidence on the effectiveness of psychological interventions for people with paraphilias in the criminal justice system. An individual patient data analysis of existing large scale data sets of paedophiles who have been treated in the criminal justice system should be conducted to inform the choice of treatment and the design of any future research. Psychological interventions for paraphilias (such as sex offender treatment programme) should be tested in large randomised controlled trials in criminal justice populations. This research could have a significant impact upon updates of this guideline.

Important outcomes could include:

  • Offending and re-offending rates
  • Effect on mental health problems
  • Cost-effectiveness
  • Health-related quality of life

While designing the trials, consideration should be given to the timing, intensity and duration of interventions in the context of the criminal justice system.

6.8. Review question: For adults with acquired cognitive impairment who are in contact with the criminal justice system, what are the benefits and harms of psychological, social or pharmacological interventions aimed at rehabilitation?

The review protocol summary, including the review question and the eligibility criteria used for this section of the guideline, can be found in Table 144. A complete list of review questions and review protocols can be found in Appendix F; further information about the search strategy can be found in Appendix H.

Table 144. Clinical review protocol summary for the review of psychological, social or pharmacological interventions aimed at rehabilitation of adults with acquired cognitive impairment (ACI) in contact with the criminal justice system.

Table 144

Clinical review protocol summary for the review of psychological, social or pharmacological interventions aimed at rehabilitation of adults with acquired cognitive impairment (ACI) in contact with the criminal justice system.

6.8.1. Clinical evidence

No directly relevant RCTs or systematic reviews were found to address this review question and when agreeing the review protocol GC decided it would be inappropriate to descend the evidence hierarchy as they were aware, on the basis of their existing knowledge of the literature, that it was unlikely to be fruitful and was therefore not considered a good use of time and resource.

In the absence of direct evidence, indirect evidence from populations outside of the criminal justice system was considered. The GC decided that extrapolation from non-criminal justice populations was potentially useful because acquired cognitive impairment is a common sequela of acquired brain injury regardless of population.

Seven systematic reviews of various interventions designed to remediate difficulties associated with ACI were identified. These are summarised narratively below. Summary study characteristics can be found within Table 145. Full details of these reviews can be found in Appendix N. As this was a narrative overview of these systematic reviews GRADE analysis was not conducted, because the evidence was not yet summarised by comparisons and outcomes at this stage. After considering the overview it was decided that further analysis according to study design (RCT versus observational study), intervention or outcome would be unlikely to alter the committee’s conclusions, given that in general no clinically significant improvements were observed. The evidence was considered low quality because it was not from non-criminal justice populations.

The systematic reviews identified spanned a range of different disorders associated with acquired cognitive impairment, some progressive and some static; mild cognitive impairment as a precursor to dementia (Cooper 2013), epilepsy (Farina 2015), various neurological conditions (Krasny-Pacini 2013), multiple sclerosis (O’Brien 2008), stroke (Whyte 2011) and stroke as well as other acquired, non-progressive brain injuries (Chung 2013) and (Coleman 2015). The terms ABI (acquired brain injury) and TBI (traumatic brain injury) are used throughout this section as they have been by review authors. ABI is used to describe non-degenerative acquired brain injuries including stroke and impact-related injuries. TBI is specifically used to describe brain injury resulting from head trauma, such as that acquired in a car crash or whilst playing sports.

Whyte 2011 and Chung 2013 both conducted reviews of rehabilitative interventions for stroke and other acquired, non-progressive brain injuries. Whyte 2011 was a narrative review identifying two broad targets for intervention; adaptation and remediation. They note that the difficulties associated with ABI can make engagement with therapeutic interventions more challenging and that there is little evidence for remediation of deficits at present, but that theoretically high frequency repetition (i.e. intense neuro-rehabilitation) may be beneficial. The Chung 2013 (N=770) paper was a Cochrane review focusing on cognitive rehabilitation for executive dysfunction, which is commonly impaired in people with ACI. They included randomised studies looking at restorative or adaptive interventions and compensatory strategies for TBI, stroke or ‘other acquired brain injury’. All included studies compared the intervention of interest with no treatment, placebo or another active intervention. 3 included studies compared cognitive rehabilitation with sensorimotor therapy, 6 compared cognitive rehabilitation with no treatment or placebo, 10 compared different rehabilitative approaches. Only 2 studies (N=82) reported data on a primary outcome (global executive function measured with the Behavioural Assessment of Dysexecutive Syndrome [BADS], Chung 2007 and Spike 2010), demonstrating no clinically significant effect. Krasny-Pacini 2013 (N=n/r) was a narrative review of a mixture of RCTs and case-reports focussed on a specific rehabilitative technique called ‘Goal Management Training’ (GMT). 4 ‘proof-of-principle’ studies and 8 experimental studies concerned with implementing the technique in practice were included. The authors concluded that GMT may have some benefits in terms of adaptive functioning, but that if used it would be more efficacious as part of a comprehensive rehabilitative package.

Coleman 2015 (N=388) also conducted a systematic review of assessment (8 studies) and intervention (2 studies) delivered via tele-practice for acquired, non-degenerative brain injuries including TBI and stroke. The 2 studies investigating rehabilitative interventions both compared different forms of problem solving training, 1 with the same intervention delivered instead in person and 1 with a control group. The authors found that there was no positive effect on cognitive skills following participation in these interventions.

Cooper 2013 (N=7,896) systematically reviewed RCTs looking at any intervention intended for mild cognitive impairment on cognitive, neuropsychiatric or functional outcomes, quality of life and the onset of dementia. The focus was on preventing further decline, rather than rehabilitation. This review included 41 placebo-controlled papers, 20 of which included primary outcomes, 9 of which investigated psychological interventions, 5 of which investigated exercise interventions and 22 of which investigated pharmacological or dietary interventions. The authors concluded that there was no replicated evidence that any intervention was effective.

Table 145. Study characteristics for the narrative review of rehabilitative interventions for acquired cognitive impairment in the criminal justice system.

Table 145

Study characteristics for the narrative review of rehabilitative interventions for acquired cognitive impairment in the criminal justice system.

6.8.2. Expert testimony

Professor Huw Williams, Associate Professor of Clinical Neuropsychology and Co-Director of the Centre for Clinical Neuropsychology Research (CCNR) at Exeter University, provided expert testimony on the relationship between traumatic brain injury (TBI) and mental health problems in young offenders. This is described in greater detail in his own words within Appendix W. The guideline committee sought this expert testimony due to the lack of direct evidence about the rehabilitation of adults with acquired cognitive impairment in contact with the criminal justice system.

Professor Williams highlighted to the GC the high prevalence of TBI in individuals in contact with the criminal justice system and the strong correlations between TBI and mental health problems, in particular substance misuse, self-harm and suicide. He also described the economic and social cost of this link. Professor Williams provided theoretical reasoning and pre-clinical evidence for this association and areas of potential focus for intervention. Professor Williams argued that identification of individuals with a history of TBI is key and that more research is required to identify ways of supporting this group.

6.8.3. Economic evidence

No studies assessing the cost effectiveness of psychological, social or pharmacological interventions for adults with acquired cognitive impairment who are in contact with the criminal justice system were identified by the systematic search of the economic literature undertaken for this guideline. Details on the methods used for the systematic search of the economic literature are described in Chapter 3.

6.8.4. Clinical evidence statements

No direct evidence was found about the effect of rehabilitative interventions on cognitive or adaptive functioning and offending outcomes in people with cognitive impairment in contact with the criminal justice system.

Low quality, indirect evidence from 7 systematic reviews (N>10,481) of studies conducted in non-criminal justice populations indicated no clinically significant improvement in cognitive or adaptive functioning from a range of interventions including psychological, pharmacological and adaptive interventions that could be considered for the remediation of deficits associated with ACI.

6.8.5. Economic evidence statements

No evidence on the cost effectiveness of psychological, social or pharmacological interventions for adults with acquired cognitive impairment who are in contact with the criminal justice system is available.

6.9. Recommendations and link to evidence

Recommendations No recommendation made
Relative values of different outcomesThe GC agreed that, given the high prevalence of acquired cognitive impairment (ACI) in the criminal justice population, identification was very important, even if no appropriate rehabilitative interventions are currently available. This is because knowledge of the presence of ACI could impact on an understanding of a person’s problems and contribute to the development of any care or management plan.
Trade-off between clinical benefits and harmsThere was no direct evidence related to the use of interventions to manage ACI in the criminal justice system or provide direct evidence on any harms. The GC agreed that there was a potentially significant clinical benefit from identifying service users who had experienced ACI. Identification may assist with clinical decision making, development of management plans and the assessment of risk. This may, in time, contribute to overall better care and management in the criminal justice system and the NHS and possibly to a reduction in criminal activity. The GC did not identify any harms associated with this other than the possible harms associated with a false positive arising from inaccurate identification. In developing recommendations in this area the GC drew on expert testimony and used informal consensus to develop their recommendations
Trade-off between net health benefits and resource useThere was no evidence on the cost-effectiveness of interventions for people with acquired cognitive impairment who are in contact with the criminal justice system. The GC expressed the view that any additional costs associated with the identification, assessment and provision of appropriate care are likely to be offset by the negative consequences associated with lack of knowledge of the presence of the acquired cognitive impairment and inadequately developed care plans. The GC considered the increased rate of ACI in this population and associated health care costs. The potential lifelong physical and mental problems caused by ACI (many psychological conditions are more prevalent in this population) is associated with high health care costs. The GC also considered the link between ACI and greater convictions, violence and the associated increase in the costs to the criminal justice system.
Quality of evidenceNo direct evidence was found for interventions to remediate difficulties associated with ACI in adults within the criminal justice system. In the absence of direct evidence on interventions for people with ACI, indirect low quality evidence on cognitive rehabilitation of ACI with multiple, different causes from 7 systematic reviews (no one of which focused exclusively on ACI) was considered, as well as expert testimony. They showed limited evidence of some benefit when particular cognitive functions were targeted by interventions (for example short-term memory function, attention, executive function), which was not directly related to ACI or, in the view of the GC, could not be applied to ACI. The absence of populations drawn from the criminal justice system, the laboratory based and experimental nature of a number of the interventions and limited testing in routine health care settings in these reviews also contributed to the GC not being able to make any recommendations for specific interventions for ACI.
Other considerationsThe GC agreed that it was important to make recommendations relating to the identification of ACI in this group even though there was no high quality evidence showing that interventions can remediate the deficits associated with ACI. This was because these service users have a higher risk of self-harm. An awareness of the presence of ACI could help a person better adapt and this information might also inform the general care and management of a person.

On this basis the GC decided that a question should be added to the first stage of reception screening in prison to facilitate identification of ACI. They agreed that a recommendation should be made for staff to receive training on the impact of ACI in service users within the criminal justice system.

The GC were aware of evidence for the remediation and management of ACI in healthcare settings outside of the criminal justice system. Given the lack of high quality evidence in a condition with a high prevalence in the criminal justice population and the potentially significant implications of the absence of any effective remedial interventions, the GC, decided to make a research recommendation to assess the effectiveness of remedial interventions for ACI in the criminal justice system.

6.9.1. Research recommendations (see also Appendix G)

7.

What interventions are clinically effective and cost-effective for the remediation of difficulties associated with acquired brain injuries (including TBI) in adults with mental health problems within the criminal justice system?

Acquired brain injuries are common in adults in contact with the criminal justice system and are associated with an increased prevalence of mental health problems including increased suicidal risk and an increased risk of re-offending. Recognition of ACI is poor and there is currently no effective intervention used in the criminal justice system to address the problems presented by ACI. This leads to poor management in the criminal justice system and poor longer term outcomes in terms of mental health and offending. There is limited evidence on effective models to remediate the consequences of ACI in the general population but no evidence for remediative interventions in the adult criminal justice population. A programme of research and development is required, which will (a) develop novel interventions for remediation specially to address the type of ACI commonly seen in the adult criminal justice system population, (b) test these interventions in small pilot studies and (c) if the pilot studies show promise test the interventions in large scale randomised clinical trials in the criminal justice system

Important outcomes could include:

  • Improved adaptive functioning
  • Improved cognitive performance
  • Improved mental health
  • Reductions in offending
  • Service utilisation

6.10. Review question: For adults with a personality disorder (other than antisocial or borderline personality disorder) who are in contact with the criminal justice system, what are the benefits and harms of psychological, social or pharmacological interventions aimed at reducing personality disorder symptomatology, or preventing or reducing offending or reoffending?

The review protocol summary, including the review question and the eligibility criteria used for this section of the guideline, can be found in Table 146. A complete list of review questions and review protocols can be found in Appendix F; further information about the search strategy can be found in Appendix H.

Table 146. Clinical review protocol summary for the review of interventions to reduce symptomatology, offending and reoffending in adults with a personality disorder other than antisocial or borderline personality disorder.

Table 146

Clinical review protocol summary for the review of interventions to reduce symptomatology, offending and reoffending in adults with a personality disorder other than antisocial or borderline personality disorder.

6.10.1. Clinical evidence for the most appropriate assessment procedures and interventions for individuals with a personality disorder within the criminal justice system

No RCT evidence was identified for this question. The GC decided it would be inappropriate to descend the evidence hierarchy as they were aware, on the basis of their existing knowledge of the literature, that it was unlikely to be fruitful and was therefore not considered a good use of time and resource and given the very high prevalence of personality disorders among people in contact with the criminal justice system any recommendations about assessments or interventions could have significant cost impact and should not be based on low quality evidence from non-randomised studies. They decided that extrapolation from non-criminal justice populations would not be appropriate as the criminal justice system is very different from other settings. The GC therefore decided to develop a set of principles to inform assessment and intervention for personality disorders within this population using a modified form of the nominal group technique. The method used for the nominal group technique is described in full within the methods section in Chapter 3.

Key issues related to assessment and intervention within this population were identified through a range of sources and from discussions within the GC meetings. These issues were used to generate nominal statements covering a range of areas that had been identified as important by the GC. These included an understanding of how a personality disorder diagnosis may impact upon psychological wellbeing and interpersonal skills, about common co-occurring difficulties within this group and the ways that interventions should be delivered to best support service users. These statements were grouped together in the form of a questionnaire and distributed to the GC to be rated. An example of statement that was rated highly by the committee is ‘People with personality disorders should not be excluded from any health or social care service because of their diagnosis’.

The questionnaire was completed by 12 of the 19 GC members. Some members were unable to attend the relevant committee meeting. However, they had the opportunity to discuss the statements from the nominal group process and contributed to the subsequent recommendations. Percentage consensus values were calculated and comments collated, for each statement. The rankings and comments were then presented to the GC members and used to inform a structured discussion within the GC meeting. Agreement within the GC was high enough that a second round of ratings was not deemed necessary. This discussion led to the development of recommendations in this area. A brief summary of the outcome of this process is depicted in Table 147 below. The full list of statements and ratings can be found in Appendix V and blank copies of the questionnaires used can be found in Appendix U.

Table 147. Summary of the nominal group technique process followed for the development of recommendations for the care, assessment and interventions for people with a personality disorder within the criminal justice system.

Table 147

Summary of the nominal group technique process followed for the development of recommendations for the care, assessment and interventions for people with a personality disorder within the criminal justice system.

6.10.2. Economic evidence

No studies assessing the cost effectiveness of psychological, social or pharmacological interventions for adults with a personality disorder (other than antisocial or borderline personality disorder) who are in contact with the criminal justice system were identified by the systematic search of the economic literature undertaken for this guideline. Details on the methods used for the systematic search of the economic literature are described in Chapter 3.

6.10.3. Clinical evidence statements based upon formal consensus ratings

The GC endorsed statements relating to principles of care stating that:

  • a personality disorder diagnosis should not result in preventing service users accessing services
  • staff should be aware that this population may have longstanding impairments in a range of areas of functioning including interpersonal difficulties, that structure and clear expectations are helpful for this group of service users and that a personality disorder diagnosis may complicate treatment of co-occurring disorders
  • it is important to be both validating and judiciously challenging when interacting with these service users.

Regarding assessment, the GC endorsed statements stating that staff should:

  • be able to identify and appropriately adjust for common features of a personality disorder
  • be aware that these service users may struggle to interpret and manage emotions, have difficulties with impulse control, feel as though they have a lack of autonomy and have an unstable sense of self or struggle with social functioning
  • establish which other services are involved in the care of the person with a personality disorder and clarify the roles and responsibilities of each service.

Regarding interventions, the GC endorsed statements stating that:

  • if complex interventions are required these should be delivered in a multi-disciplinary setting
  • staff should ensure that adequate case management and advocacy are in place for the service user
  • interventions should be supportive, facilitate learning and encourage the development of new behaviours and that the service user should be offered interventions for any comorbid disorders in line with relevant NICE guidelines
  • staff should work alongside the service user to develop a crisis plan and assist them to feel responsible for their care
  • when changing treatments or services that a structured and phased approach should be taken
  • when developing care plans the following components should be considered; problem-solving, articulation and management of emotions, managing interpersonal relationships, impulse control, self-harm and medication management.
  • The GC expressed moderate agreement for increasing the duration or intensity of psychological interventions.

6.10.4. Economic evidence statements

No evidence on the cost effectiveness of psychological, social or pharmacological interventions for adults with a personality disorder who are in contact with the criminal justice system is available.

6.11. Recommendations and link to evidence

Recommendations
44.

Be aware that many people in contact with the criminal justice system (including people with a diagnosis of personality disorder) may have difficulties with:

  • accurately interpreting and controlling emotions
  • impulse control (for example, difficulty planning, seeking high levels of stimulation, ambivalent about consequences of their negative actions)
  • experiencing themselves as having a lack of autonomy (for example, seeing their actions as pointless, having difficulties in setting and achieving goals)
  • having an unstable sense of self that varies depending on context or is influenced by the people they interact with
  • social functioning (for example, relating to, cooperating with and forming relationships with others, difficulties understanding their own and others’ needs)
  • occupational functioning.

45.

Providers of services should ensure staff are able to identify common features and behaviours associated with personality disorders and use these to inform the development of programmes of care.

46.

Practitioners should ensure interventions for people with a diagnosis of personality disorder or associated problems are supportive, facilitate learning and develop new behaviours and coping strategies in the following areas:

  • problem solving
  • emotion regulation and impulse control
  • managing interpersonal relationships
  • self-harm
  • use of medicine (including reducing polypharmacy).

47.

Practitioners should be aware when delivering interventions for people with mental health problems that having a personality disorder or an associated problem may reduce the effectiveness of interventions. Think about:

  • providing additional support
  • adjusting the duration and intensity of psychological interventions if standard protocols have not worked
  • delivering complex interventions in a multidisciplinary context.

48.

Practitioners should not exclude people with personality disorders from any health or social care service, or intervention for comorbid disorders, as a direct result of their diagnosis.

Relative values of different outcomesThe GC discussed issues specific to work with individuals with personality disorders in the criminal justice system. This included particular difficulties with establishing and maintaining a therapeutic relationship, the need for more complex therapeutic interventions, the greater levels of risk and difficult social relationships. They noted that personality disorders are often poorly understood. People with a diagnosis of personality disorder are sometimes denied access to services as a result of this diagnosis. Despite these problems, people with personality disorder are over represented in the criminal justice population and in groups of people who make high use of emergency health care services. Effective access to services followed by prompt treatment may, therefore, have implications for improved mental health and well-being of people with a personality disorder and reduce demand on services.
Trade-off between clinical benefits and harmsThe GC discussed how greater awareness, on the part of staff, about the nature of personality disorders and information about how best to approach this group therapeutically, could have a significant positive clinical impact. They agreed that adapting interventions so that they are more structured, treatment sessions are more frequent or longer, or working alongside other professionals and collaboratively with the individual, were likely to result in improved therapeutic engagement, better clinical outcomes and less use of services in the future. They agreed that clinicians feeling confident enough to maintain structure and boundaries in therapeutic relationships is key to working with this group.

The GC agreed that given the proper adaptation of effective interventions, there would likely be no harms associated with psychosocial interventions for people with a personality disorder. Interventions may lead to a reduction in the extent of the self-harm often seen in people with personality disorder.
Trade-off between net health benefits and resource useEffective treatment for people with personality disorders is likely to lead to increased use of health service resources in the short-term. This arises from the need for more intensive, structured treatments of longer duration. However, given that such individuals are associated with higher uses of emergency health services and over represented in the prison system, effective treatment could lead to significant costs savings in the long term.
Quality of evidenceNo RCT evidence was identified that was relevant to this review. The GC used a nominal group technique to generate evidence statements to support the development of the recommendations. This evidence was of low quality and was used to make general ‘in principle’ recommendations, for this population of service users, on the basis of their expert knowledge. These statements focused on interpreting and controlling emotions, impulse control, lack of autonomy, having an unstable sense of self and social and occupational functioning. The GC agreed that these problems could be addressed and improved by interventions focused on problem solving, emotion regulation, impulse control, managing interpersonal relationships, reducing self-harm, better medicine management and adjustments to the delivery of psychological interventions.
Other considerationsThe GC were aware of the need to produce recommendations that supported the provision of effective interventions that are in line with existing NICE guidance including that on personality disorders. The GC was particularly concerned with the engagement of individuals so they could access effective NICE recommended interventions.

With this in mind and because of the limited quality of evidence in criminal justice populations, the group focused on the development of general principle recommendations. These would guide general treatments of people with personality disorders and the use of NICE guidance. Given that much evidence on personality disorder was limited to borderline and antisocial personality disorder, the GC decided to make a research recommendation for further research into psychosocial interventions for people with other kinds of personality disorder in contact with the criminal justice system.

6.11.1. Research recommendations (see also Appendix G)

8.

What psychosocial interventions are clinically and cost-effective for people with a personality disorder (other than ASPD or PBD) within the criminal justice system?

Personality disorders are common in adults in contact with the criminal justice system and are associated with an increased risk of re-offending, increased self-harm and suicidality and increased drug and alcohol misuse. Personality disorder may also contribute to significant management problems in the criminal justice system, these management problems may in part arise because the disorders are not recognised and potentially effective interventions are not made available. There are effective treatments for antisocial and borderline personality disorders and, in particular, antisocial personality disorder are available in the criminal justice system. However, although other types of personality disorder are also present in the criminal justice population there is very limited evidence to guide effective treatment for these problems. A programme of research and development is required which will (a) develop interventions for personality disorder (other than ASPD or PBD) within the criminal justice system specially for use in the adult criminal justice system population (b) test these interventions in a series of pilot studies and (c) if the pilot studies show promise, test the interventions in large scale randomised clinical trials in the criminal justice system

Important outcomes could include:

  • Remission of the disorder
  • Improved interpersonal performance
  • Improved mental health
  • Reductions in offending
  • Service utilisation
  • Cost effectiveness

Footnotes

h

This guideline covers the full range of mental health problems including common mental disorders, substance misuse disorders, neurodevelopmental disorders and personality disorders.

Copyright © National Institute for Health and Care Excellence, 2017.
Bookshelf ID: NBK533122

Views

  • PubReader
  • Print View
  • Cite this Page
  • PDF version of this title (3.4M)

In this Page

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...